Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges

Abstract

Cancer continues to be one of the primary causes of death worldwide. Although there has been substantial progress in clinical cancer care, the outcomes for cancer patients still remain poor. The rapid advancements of artificial intelligence (AI) will revolutionize cancer management by addressing current obstacles in oncology research and practice, ultimately enhancing healthcare accuracy and patient outcomes. Increasing evidence demonstrates that AI-based models can improve the accuracy and efficiency of cancer diagnosis and treatment by leveraging multilayer data. Cancer patients could greatly benefit from AI's promising prospects, yet few AI models have been authorized for clinical use. A comprehensive understanding of AI's basic principles, applications, and potential impacts is essential to foster its clinical translation. In this review, we provide an overview of fundamental AI techniques, encompassing machine learning and deep learning. Moreover, we summarize recent studies on AI's transformative role in cancer diagnosis, classification, and personalized treatment planning. Furthermore, we discuss the current challenges that hinder the widespread use of AI, propose potential solutions, and outline future directions. Overall, through systematic analysis of existing preclinical and clinical evidence, this review highlights the substantial potential of AI technology and provides valuable guidance for future research in AI-driven oncology.

Keywords

artificial intelligence / cancer / cancer diagnosis / prognosis prediction / personalized cancer therapy

References

[1] F. Bray, M. Laversanne, H. Sung, et al., “Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 74, no. 3 (2024): 229-263.

[2] A. E. Yuzhalin, “Redefining Cancer Research for Therapeutic Breakthroughs,” British Journal of Cancer 130, no. 7 (2024): 1078-1082.

[3] R. C. Fitzgerald, A. C. Antoniou, L. Fruk, and N. Rosenfeld, “The Future of Early Cancer Detection,” Nature Medicine 28, no. 4 (2022): 666-677.

[4] M. Arruebo, N. Vilaboa, B. Saez-Gutierrez, et al., “Assessment of the Evolution of Cancer Treatment Therapies,” Cancers (Basel) 3, no. 3 (2011): 3279-3330.

[5] Y. Q. Liu, X. L. Wang, D. H. He, and Y. X. Cheng, “Protection Against Chemotherapy- and Radiotherapy-induced Side Effects: A Review Based on the Mechanisms and Therapeutic Opportunities of Phytochemicals,” Phytomedicine 80 (2021): 153402.

[6] A. H. Gunn, C. Sorenson, and R. A. Greenup, “Navigating the High Costs of Cancer Care: Opportunities for Patient Engagement,” Future Oncology 17, no. 28 (2021): 3729-3742.

[7] K. Shahid, M. Khalife, R. Dabney, and A. T. Phan, “Immunotherapy and Targeted Therapy-the New Roadmap in Cancer Treatment,” Annals of Translational Medicine 7, no. 20 (2019): 595.

[8] L. Zhu, M. Jiang, H. Wang, et al., “A Narrative Review of Tumor Heterogeneity and Challenges to Tumor Drug Therapy,” Annals of Translational Medicine 9, no. 16 (2021): 1351.

[9] Y. Zhang and Z. Zhang, “The History and Advances in Cancer Immunotherapy: Understanding the Characteristics of Tumor-infiltrating Immune Cells and Their Therapeutic Implications,” Cellular & Molecular Immunology 17, no. 8 (2020): 807-821.

[10] S. Hussain, I. Mubeen, N. Ullah, et al., “Modern Diagnostic Imaging Technique Applications and Risk Factors in the Medical Field: A Review,” BioMed Research International 2022 (2022): 5164970.

[11] S. Das, M. K. Dey, R. Devireddy, and M. R. Gartia, “Biomarkers in Cancer Detection, Diagnosis, and Prognosis,” Sensors (Basel) 24, no. 1 (2023): 37.

[12] A. M. Sebastian and D. Peter, “Artificial Intelligence in Cancer Research: Trends, Challenges and Future Directions,” Life (Basel) 12, no. 12 (2022): 1991.

[13] J. Guo, J. Hu, Y. Zheng, S. Zhao, and J. Ma, “Artificial Intelligence: Opportunities and Challenges in the Clinical Applications of Triple-negative Breast Cancer,” British Journal of Cancer 128, no. 12 (2023): 2141-2149.

[14] V. Bellini, M. Cascella, F. Cutugno, et al., “Understanding Basic Principles of Artificial Intelligence: A Practical Guide for Intensivists,” Acta Biomedica 93, no. 5 (2022): e2022297.

[15] Q. Pei, Y. Luo, Y. Chen, J. Li, D. Xie, and T. Ye, “Artificial Intelligence in Clinical Applications for Lung Cancer: Diagnosis, Treatment and Prognosis,” Clinical Chemistry and Laboratory Medicine 60, no. 12 (2022): 1974-1983.

[16] C. D. Naylor, “On the Prospects for a (deep) Learning Health Care System,” Jama 320, no. 11 (2018): 1099-1100.

[17] F. Deng, J. Huang, X. Yuan, C. Cheng, and L. Zhang, “Performance and Efficiency of Machine Learning Algorithms for Analyzing Rectangular Biomedical Data,” Laboratory Investigation 101, no. 4 (2021): 430-441.

[18] Y. LeCun, Y. Bengio, and G. Hinton, “Deep Learning,” Nature 521, no. 7553 (2015): 436-444.

[19] B. Bhinder, C. Gilvary, N. S. Madhukar, and O. Elemento, “Artificial Intelligence in Cancer Research and Precision Medicine,” Cancer Discovery 11, no. 4 (2021): 900-915.

[20] H. Silva, G. N. M. Santos, A. F. Leite, et al., “The Use of Artificial Intelligence Tools in Cancer Detection Compared to the Traditional Diagnostic Imaging Methods: An Overview of the Systematic Reviews,” PLoS ONE 18, no. 10 (2023): e0292063.

[21] A. Aamir, A. Iqbal, F. Jawed, et al., “Exploring the Current and Prospective Role of Artificial Intelligence in Disease Diagnosis,” Annals of Medicine and Surgery (London) 86, no. 2 (2024): 943-949.

[22] S. Askin, D. Burkhalter, G. Calado, and S. El Dakrouni, “Artificial Intelligence Applied to Clinical Trials: Opportunities and Challenges,” Health and Technology (Berlin) 13, no. 2 (2023): 203-213.

[23] S. Maleki Varnosfaderani and M. Forouzanfar, “The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century,” Bioengineering (Basel) 11, no. 4 (2024): 337.

[24] D. Dixon, H. Sattar, N. Moros, et al., “Unveiling the Influence of AI Predictive Analytics on Patient Outcomes: A Comprehensive Narrative Review,” Cureus 16, no. 5 (2024): e59954.

[25] A. Dubey and A. Tiwari, “Artificial Intelligence and Remote Patient Monitoring in US Healthcare Market: A Literature Review,” Journal of Market Access & Health Policy 11, no. 1 (2023): 2205618.

[26] E. Sezgin, “Artificial Intelligence in Healthcare: Complementing, Not Replacing, Doctors and Healthcare Providers,” Digital Health 9 (2023): 20552076231186520.

[27] D. Henzler, S. Schmidt, A. Kocar, et al., “Healthcare Professionals' perspectives on Artificial Intelligence in Patient Care: A Systematic Review of Hindering and Facilitating Factors on Different Levels,” BMC Health Services Research [Electronic Resource] 25, no. 1 (2025): 633.

[28] Y. Balagurunathan, R. Mitchell, and I. El Naqa, “Requirements and Reliability of AI in the Medical Context,” Physical Medicine 83 (2021): 72-78.

[29] K. Palaniappan, E. Y. T. Lin, and S. Vogel, “Global Regulatory Frameworks for the Use of Artificial Intelligence (AI) in the,” Healthcare Services Sector Healthcare (Basel) 12, no. 5 (2024): 562.

[30] D. D. Farhud and S. Zokaei, “Ethical Issues of Artificial Intelligence in Medicine and Healthcare,” Iranian Journal of Public Health 50, no. 11 (2021): i-v.

[31] N. Bienefeld, E. Keller, and G. Grote, “AI Interventions to Alleviate Healthcare Shortages and Enhance Work Conditions in Critical Care: Qualitative Analysis,” Journal of Medical Internet Research [Electronic Resource] 27 (2025): e50852.

[32] H. Shamszare and A. Choudhury, “Clinicians' Perceptions of Artificial Intelligence: Focus on Workload, Risk, Trust, Clinical Decision Making, and Clinical Integration,” Healthcare (Basel) 11, no. 16 (2023): 2308.

[33] T. Lysaght, H. Y. Lim, V. Xafis, and K. Y. Ngiam, “AI-Assisted Decision-making in Healthcare: The Application of an Ethics Framework for Big Data in Health and Research,” Asian Bioethics Review 11, no. 3 (2019): 299-314.

[34] P. Esmaeilzadeh, “Challenges and Strategies for Wide-scale Artificial Intelligence (AI) Deployment in Healthcare Practices: A Perspective for Healthcare Organizations,” Artificial Intelligence in Medicine 151 (2024): 102861.

[35] T. P. Quinn, M. Senadeera, S. Jacobs, S. Coghlan, and V. Le, “Trust and Medical AI: The Challenges We Face and the Expertise Needed to Overcome Them,” Journal of the American Medical Informatics Association 28, no. 4 (2021): 890-894.

[36] S. Huang, J. Yang, N. Shen, Q. Xu, and Q. Zhao, “Artificial Intelligence in Lung Cancer Diagnosis and Prognosis: Current Application and Future Perspective,” Seminars in Cancer Biology 89 (2023): 30-37.

[37] J. Calderaro, L. Zigutyte, D. Truhn, A. Jaffe, and J. N. Kather, “Artificial Intelligence in Liver Cancer—new Tools for Research and Patient Management,” Nature Reviews Gastroenterology & Hepatology 21, no. 8 (2024): 585-599.

[38] A. D. Haue, J. X. Hjaltelin, P. C. Holm, D. Placido, and S. R. Brunak, “Artificial Intelligence-aided Data Mining of Medical Records for Cancer Detection and Screening,” The Lancet Oncology 25, no. 12 (2024): e694-e703.

[39] M. Krassowski, V. Das, S. K. Sahu, and B. B. Misra, “State of the Field in Multi-Omics Research: From Computational Needs to Data Mining and Sharing,” Frontiers in Genetics 11 (2020): 610798.

[40] Y. M. Chen, T. H. Hsiao, C. H. Lin, and Y. C. Fann, “Unlocking Precision Medicine: Clinical Applications of Integrating Health Records, Genetics, and Immunology Through Artificial Intelligence,” Journal of Biomedical Science 32, no. 1 (2025): 16.

[41] B. Van Calster, L. Wynants, D. Timmerman, E. W. Steyerberg, and G. S. Collins, “Predictive Analytics in Health Care: How Can We Know It Works?,” Journal of the American Medical Informatics Association 26, no. 12 (2019): 1651-1654.

[42] N. Akhoon, “Precision Medicine: A New Paradigm in Therapeutics,” International Journal of Preventive Medicine 12 (2021): 12.

[43] N. Afzal, S. Sohn, S. Abram, et al., “Mining Peripheral Arterial Disease Cases From Narrative Clinical Notes Using Natural Language Processing,” Journal of Vascular Surgery 65, no. 6 (2017): 1753-1761.

[44] J. Gazquez-Garcia, C. L. Sanchez-Bocanegra, and J. L. Sevillano, “AI in the Health Sector: Systematic Review of Key Skills for Future Health Professionals,” JMIR Medical Education 11 (2025): e58161.

[45] S. Badillo, B. Banfai, F. Birzele, et al., “An Introduction to Machine Learning,” Clinical Pharmacology & Therapeutics 107, no. 4 (2020): 871-885.

[46] H. Habehh and S. Gohel, “Machine Learning in Healthcare,” Current Genomics 22, no. 4 (2021): 291-300.

[47] N. Murali, A. Kucukkaya, A. Petukhova, J. Onofrey, and J. Chapiro, “Supervised Machine Learning in Oncology: A Clinician's Guide,” Digestive Disease Interventions 4, no. 1 (2020): 73-81.

[48] T. Jiang, J. L. Gradus, and A. J. Rosellini, “Supervised Machine Learning: A Brief Primer,” Behavior Therapy 51, no. 5 (2020): 675-687.

[49] E. Christodoulou, J. Ma, G. S. Collins, E. W. Steyerberg, J. Y. Verbakel, and B. Van Calster, “A Systematic Review Shows no Performance Benefit of Machine Learning Over Logistic Regression for Clinical Prediction Models,” Journal of Clinical Epidemiology 110 (2019): 12-22.

[50] M. Kim, J. Yun, Y. Cho, et al., “Deep Learning in Medical Imaging,” Neurospine 16, no. 4 (2019): 657-668.

[51] V. Rani, S. T. Nabi, M. Kumar, A. Mittal, and K. Kumar, “Self-supervised Learning: A Succinct Review,” Archives of Computational Methods in Engineering 30, no. 4 (2023): 2761-2775.

[52] Y. Xie, Z. Xu, J. Zhang, Z. Wang, and S. Ji, “Self-Supervised Learning of Graph Neural Networks: A Unified Review,” Ieee Transactions on Pattern Analysis and Machine Intelligence 45, no. 2 (2023): 2412-2429.

[53] S. Albelwi, “Survey on Self-Supervised Learning: Auxiliary Pretext Tasks and Contrastive Learning Methods in Imaging,” Entropy (Basel) 24, no. 4 (2022): 551.

[54] F. Navarro, C. Watanabe, S. Shit, et al., “Self-Supervised Pretext Tasks in Model Robustness & Generalizability: A Revisit From Medical Imaging Perspective,” Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2022 (2022): 5074-5079.

[55] H. Pan, Y. Guo, Q. Deng, H. Yang, J. Chen, and Y. Chen, “Improving Fine-tuning of Self-supervised Models With Contrastive Initialization,” Neural Networks 159 (2023): 198-207.

[56] S. J. Wagner, D. Reisenbuchler, N. P. West, et al., “Transformer-based Biomarker Prediction From Colorectal Cancer Histology: A Large-scale Multicentric Study,” Cancer Cell 41, no. 9 (2023): 1650-1661. e4.

[57] A. Claudio Quiros, N. Coudray, A. Yeaton, et al., “Mapping the Landscape of Histomorphological Cancer Phenotypes Using Self-supervised Learning on Unannotated Pathology Slides,” Nature Communications 15, no. 1 (2024): 4596.

[58] N. Akalin and A. Loutfi, “Reinforcement Learning Approaches in Social Robotics,” Sensors (Basel) 21, no. 4 (2021): 1292.

[59] R. Nian, J. Liu, and B. Huang, “A Review on Reinforcement Learning: Introduction and Applications in Industrial Process Control,” Computers & Chemical Engineering 139 (2020): 106886.

[60] M. N. A. Al-Hamadani, M. A. Fadhel, L. Alzubaidi, and H. Balazs, “Reinforcement Learning Algorithms and Applications in Healthcare and Robotics: A Comprehensive and Systematic Review,” Sensors (Basel) 24, no. 8 (2024): 2461.

[61] H. Elmekki, S. Islam, A. Alagha, et al., “Comprehensive Review of Reinforcement Learning for Medical Ultrasound Imaging,” Artificial Intelligence Review 58, no. 9 (2025): 284.

[62] G. Molinaro and A. G. E. Collins, “Intrinsic Rewards Explain Context-sensitive Valuation in Reinforcement Learning,” Plos Biology 21, no. 7 (2023): e3002201.

[63] T. C. Frommeyer, M. M. Gilbert, R. M. Fursmidt, et al., “Reinforcement Learning and Its Clinical Applications within Healthcare: A Systematic Review of Precision Medicine and Dynamic Treatment Regimes,” Healthcare (Basel) 13, no. 14 (2025): 1752.

[64] T. Qamar and N. Z. Bawany, “Understanding the Black-box: Towards Interpretable and Reliable Deep Learning Models,” PeerJ Computer Science 9 (2023): e1629.

[65] L. Alzubaidi, J. Zhang, A. J. Humaidi, et al., “Review of Deep Learning: Concepts, CNN Architectures, Challenges, Applications, Future Directions,” Journal of Big Data 8, no. 1 (2021): 53.

[66] J. M. Vaz and S. Balaji, “Convolutional Neural Networks (CNNs): Concepts and Applications in Pharmacogenomics,” Molecular Diversity 25, no. 3 (2021): 1569-1584.

[67] T. Ersavas, M. A. Smith, and J. S. Mattick, “Novel Applications of Convolutional Neural Networks in the Age of Transformers,” Scientific Reports 14, no. 1 (2024): 10000.

[68] A. B, M. Kaur, D. Singh, S. Roy, and M. Amoon, “Efficient Skip Connections-Based Residual Network (ESRNet) for Brain Tumor Classification,” Diagnostics (Basel) 13, no. 20 (2023): 3234.

[69] Z. Zhou, J. Shin, L. Zhang, S. Gurudu, M. Gotway, and J. Liang, “Fine-tuning Convolutional Neural Networks for Biomedical Image Analysis: Actively and Incrementally,” Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition 2017 (2017): 4761-4772.

[70] J. Noorbakhsh, S. Farahmand, A. Foroughi Pour, et al., “Deep Learning-based Cross-classifications Reveal Conserved Spatial Behaviors Within Tumor Histological Images,” Nature Communications 11, no. 1 (2020): 6367.

[71] S. Nerella, S. Bandyopadhyay, J. Zhang, et al., “Transformers and Large Language Models in Healthcare: A Review,” Artificial Intelligence in Medicine 154 (2024): 102900.

[72] S. R. Choi and M. Lee, “Transformer Architecture and Attention Mechanisms in Genome Data Analysis: A Comprehensive Review,” Biology (Basel) 12, no. 7 (2023): 1033.

[73] G. Tucudean, M. Bucos, B. Dragulescu, and C. D. Caleanu, “Natural Language Processing With Transformers: A Review,” PeerJ Computer Science 10 (2024): e2222.

[74] X. Lin, L. Yu, K. T. Cheng, and Z. Yan, “The Lighter the Better: Rethinking Transformers in Medical Image Segmentation through Adaptive Pruning,” IEEE Transactions on Medical Imaging 42, no. 8 (2023): 2325-2337.

[75] R. Wang, V. Bashyam, Z. Yang, et al., “Applications of Generative Adversarial Networks in Neuroimaging and Clinical Neuroscience,” Neuroimage 269 (2023): 119898.

[76] M. H. Akpinar, A. Sengur, M. Salvi, et al., “Synthetic Data Generation via Generative Adversarial Networks in Healthcare: A Systematic Review of Image- and Signal-Based Studies,” IEEE Open Journal of Engineering in Medicine and Biology 6 (2025): 183-192.

[77] S. P. Porkodi, V. Sarada, V. Maik, and K. Gurushankar, “Generic Image Application Using GANs (Generative Adversarial Networks): A Review,” Evolving Systems (Berlin) (2022): 1-15.

[78] Y. J. Yeo, Y. G. Shin, S. Park, and S. J. Ko, “Simple yet Effective Way for Improving the Performance of GAN,” IEEE Transactions on Neural Networks and Learning Systems 33, no. 4 (2022): 1811-1818.

[79] J. J. Jeong, A. Tariq, T. Adejumo, H. Trivedi, J. W. Gichoya, and I. Banerjee, “Systematic Review of Generative Adversarial Networks (GANs) for Medical Image Classification and Segmentation,” Journal of Digital Imaging 35, no. 2 (2022): 137-152.

[80] Y. Zhang and J. Hong, “Challenges of Deep Learning in Cancers,” Technology in Cancer Research & Treatment 22 (2023): 15330338231173495.

[81] S. Pati, S. Kumar, A. Varma, et al., “Privacy Preservation for Federated Learning in Health Care,” Patterns (N Y) 5, no. 7 (2024): 100974.

[82] B. Yurdem, M. Kuzlu, M. K. Gullu, F. O. Catak, and M. Tabassum, “Federated Learning: Overview, Strategies, Applications, Tools and Future Directions,” Heliyon 10, no. 19 (2024): e38137.

[83] L. Che, J. Wang, Y. Zhou, and F. Ma, “Multimodal Federated Learning: A Survey,” Sensors (Basel) 23, no. 15 (2023): 6986.

[84] Y. Shi, J. Zhang, M. Xue, et al., “Vertical Federated Learning Based on Data Subset Representation for Healthcare Application,” Computer Methods and Programs in Biomedicine 263 (2025): 108623.

[85] I. Kholod, E. Yanaki, D. Fomichev, et al., “Open-Source Federated Learning Frameworks for IoT: A Comparative Review and Analysis,” Sensors (Basel) 21, no. 1 (2020): 167.

[86] A. Tahir, F. Chen, H. U. Khan, Z. Ming, A. Ahmad, and S. Nazir, “A Systematic Review on Cloud Storage Mechanisms Concerning e-Healthcare Systems,” Sensors (Basel) 20, no. 18 (2020): 5392.

[87] E. Alalwany and I. Mahgoub, “Security and Trust Management in the Internet of Vehicles (IoV): Challenges and Machine Learning Solutions,” Sensors (Basel) 24, no. 2 (2024): 368.

[88] A. Bourechak, O. Zedadra, M. N. Kouahla, A. Guerrieri, H. Seridi, and G. Fortino, “At the Confluence of Artificial Intelligence and Edge Computing in IoT-Based Applications: A Review and New Perspectives,” Sensors (Basel) 23, no. 3 (2023): 1639.

[89] R. Vano, I. Lacalle, P. Sowinski, R. S-Julián, and C. E. Palau, “Cloud-Native Workload Orchestration at the Edge: A Deployment Review and Future Directions,” Sensors (Basel) 23, no. 4 (2023): 2215.

[90] M. Babar, M. Ahmad Jan, X. He, M. Usman Tariq, S. Mastorakis, and R. Alturki, “An Optimized IoT-enabled Big Data Analytics Architecture for Edge-Cloud Computing,” IEEE Internet of Things Journal 10, no. 5 (2023): 3995-4005.

[91] S. Hamdan, M. Ayyash, and S. Almajali, “Edge-Computing Architectures for Internet of Things Applications: A Survey,” Sensors (Basel) 20, no. 22 (2020): 6441.

[92] A. Garcia-Perez, R. Minon, A. I. Torre-Bastida, and E. Zulueta-Guerrero, “Analysing Edge Computing Devices for the Deployment of Embedded AI,” Sensors (Basel) 23, no. 23 (2023): 9495.

[93] O. Ali, M. K. Ishak, M. K. L. Bhatti, I. Khan, and K. I. Kim, “A Comprehensive Review of Internet of Things: Technology Stack, Middlewares, and Fog/Edge Computing Interface,” Sensors (Basel) 22, no. 3 (2022): 995.

[94] N. A. Angel, D. Ravindran, P. Vincent, K. Srinivasan, and Y. C. Hu, “Recent Advances in Evolving Computing Paradigms: Cloud, Edge, and Fog Technologies,” Sensors (Basel) 22, no. 1 (2021): 196.

[95] D. C. Klonoff, “Fog Computing and Edge Computing Architectures for Processing Data from Diabetes Devices Connected to the Medical Internet of Things,” Journal of Diabetes Science and Technology 11, no. 4 (2017): 647-652.

[96] G. Carvalho, B. Cabral, V. Pereira, and J. Bernardino, “Edge Computing: Current Trends, Research Challenges and Future Directions,” Computing 103, no. 5 (2021): 993-1023.

[97] L. Belcastro, J. Carretero, and D. Talia, “Edge-Cloud Solutions for Big Data Analysis and Distributed Machine Learning - 1,” Future Generation Computer Systems 159 (2024): 323-326.

[98] A. M. Alwakeel, “An Overview of Fog Computing and Edge Computing Security and Privacy Issues,” Sensors (Basel) 21, no. 24 (2021): 8226.

[99] Y. Mansouri and M. A. Babar, “A Review of Edge Computing: Features and Resource Virtualization,” Journal of Parallel and Distributed Computing 150 (2021): 155-183.

[100] S. Dash, S. K. Shakyawar, M. Sharma, and S. Kaushik, “Big Data in Healthcare: Management, Analysis and Future Prospects,” Journal of Big Data 6, no. 1 (2019): 54.

[101] Y. Gao, D. Cao, M. Li, et al., “Integration of Multiomics Features for Blood-based Early Detection of Colorectal Cancer,” Molecular Cancer 23, no. 1 (2024): 173.

[102] T. Liu, J. Huang, T. Liao, R. Pu, S. Liu, and Y. Peng, “A Hybrid Deep Learning Model for Predicting Molecular Subtypes of Human Breast Cancer Using Multimodal Data,” IRBM 43, no. 1 (2022): 62-74.

[103] O. Lapuente-Santana, G. Sturm, J. Kant, et al., “Multimodal Analysis Unveils Tumor Microenvironment Heterogeneity Linked to Immune Activity and Evasion,” Iscience 27, no. 8 (2024): 110529.

[104] Z. Liu and S. Zhang, “Tumor Characterization and Stratification by Integrated Molecular Profiles Reveals Essential Pan-cancer Features,” BMC Genomics [Electronic Resource] 16, no. 1 (2015): 503.

[105] W. G. Breen, M. P. Aryal, Y. Cao, and M. M. Kim, “Integrating Multi-modal Imaging in Radiation Treatments for Glioblastoma,” Neuro-Oncology 26, no. 12 Suppl 2 (2024): S17-S25.

[106] R. S. Vanguri, J. Luo, A. T. Aukerman, et al., “Multimodal Integration of Radiology, Pathology and Genomics for Prediction of Response to PD-(L)1 Blockade in Patients With Non-small Cell Lung Cancer,” Nature Cancer 3, no. 10 (2022): 1151-1164.

[107] K. Tan, W. Huang, X. Liu, J. Hu, and S. Dong, “A Multi-modal Fusion Framework Based on Multi-task Correlation Learning for Cancer Prognosis Prediction,” Artificial Intelligence in Medicine 126 (2022): 102260.

[108] Y. Hao, C. Cheng, J. Li, et al., “Multimodal Integration in Health Care: Development with Applications in Disease Management,” Journal of Medical Internet Research [Electronic Resource] 27 (2025): e76557.

[109] S. Khalighi, K. Reddy, A. Midya, K. B. Pandav, A. Madabhushi, and M. Abedalthagafi, “Artificial Intelligence in Neuro-oncology: Advances and Challenges in Brain Tumor Diagnosis, Prognosis, and Precision Treatment,” NPJ Precision Oncology 8, no. 1 (2024): 80.

[110] S. N. Histed, M. L. Lindenberg, E. Mena, B. Turkbey, P. L. Choyke, and K. A. Kurdziel, “Review of Functional/Anatomical Imaging in Oncology,” Nuclear Medicine Communications 33, no. 4 (2012): 349-361.

[111] C. Zhang, J. Xu, R. Tang, et al., “Novel Research and Future Prospects of Artificial Intelligence in Cancer Diagnosis and Treatment,” Journal of Hematology & Oncology 16, no. 1 (2023): 114.

[112] S. Yelne, M. Chaudhary, K. Dod, A. Sayyad, and R. Sharma, “Harnessing the Power of AI: A Comprehensive Review of Its Impact and Challenges in Nursing Science and Healthcare,” Cureus 15, no. 11 (2023): e49252.

[113] Y. Kumar, A. Koul, R. Singla, and M. F. Ijaz, “Artificial Intelligence in Disease Diagnosis: A Systematic Literature Review, Synthesizing Framework and Future Research Agenda,” Journal of Ambient Intelligence and Humanized Computing 14, no. 7 (2023): 8459-8486.

[114] R. Paudyal, A. D. Shah, O. Akin, et al., “Artificial Intelligence in CT and MR Imaging for Oncological Applications,” Cancers (Basel) 15, no. 9 (2023): 2573.

[115] S. Vedantham, H. W. Tseng, Z. Fu, and H. S. Chow, “Dedicated Cone-Beam Breast CT: Reproducibility of Volumetric Glandular Fraction With Advanced Image Reconstruction Methods,” Tomography 9, no. 6 (2023): 2039-2051.

[116] S. P. Jakkaladiki and F. Maly, “Integrating Hybrid Transfer Learning With Attention-enhanced Deep Learning Models to Improve Breast Cancer Diagnosis,” PeerJ Computer Science 10 (2024): e1850.

[117] S. Endo, K. Nagata, K. Utano, et al., “Development and Validation of Computer-aided Detection for Colorectal Neoplasms Using Deep Learning Incorporated With Computed Tomography Colonography,” BMC Gastroenterology [Electronic Resource] 25, no. 1 (2025): 149.

[118] M. Takeuchi, T. Seto, M. Hashimoto, et al., “Performance of a Deep Learning-based Identification System for Esophageal Cancer From CT Images,” Esophagus 18, no. 3 (2021): 612-620.

[119] C. Dong, T. Z. Li, K. Xu, et al., “Characterizing Browser-based Medical Imaging AI With Serverless Edge Computing: Towards Addressing Clinical Data Security Constraints,” Proceedings of Spie the International Society for Optical Engineering 12469 (2023): 1246907.

[120] R. Zahari, J. Cox, and B. Obara, “Uncertainty-aware Image Classification on 3D CT Lung,” Computers in Biology and Medicine 172 (2024): 108324.

[121] J. V. Sousa, P. Matos, F. Silva, P. Freitas, H. P. Oliveira, and T. Pereira, “Single Modality vs. Multimodality: What Works Best for Lung Cancer Screening?,” Sensors (Basel) 23, no. 12 (2023): 5597.

[122] A. Saha, S. M. Ganie, P. K. D. Pramanik, R. K. Yadav, S. Mallik, and Z. Zhao, “VER-Net: A Hybrid Transfer Learning Model for Lung Cancer Detection Using CT Scan Images,” BMC Medical Imaging 24, no. 1 (2024): 120.

[123] M. Naghavi, I. De Oliveira, S. S. Mao, et al., “Opportunistic AI-enabled Automated Bone Mineral Density Measurements in Lung Cancer Screening and Coronary Calcium Scoring CT Scans Are Equivalent,” European Journal of Radiology Open 10 (2023): 100492.

[124] S. Karimullah, M. Khan, F. Shaik, B. Alabduallah, and A. Almjally, “An Integrated Method for Detecting Lung Cancer via CT Scanning via Optimization, Deep Learning, and IoT Data Transmission,” Frontiers in Oncology 14 (2024): 1435041.

[125] U. Batra, S. Nathany, S. K. Nath, et al., “AI-based Pipeline for Early Screening of Lung Cancer: Integrating Radiology, Clinical, and Genomics Data,” Lancet Regional Health - Southeast Asia 24 (2024): 100352.

[126] S. Aslani, P. Alluri, E. Gudmundsson, et al., “Enhancing Cancer Prediction in Challenging Screen-detected Incident Lung Nodules Using Time-series Deep Learning,” Computerized Medical Imaging and Graphics 116 (2024): 102399.

[127] R. Yang, Y. Zhang, W. Li, et al., “Development and External Validation of a Multimodal Integrated Feature Neural Network (MIFNN) for the Diagnosis of Malignancy in Small Pulmonary Nodules (</= 10 mm),” Biomedical Physics & Engineering Express 10, no. 4 (2024): 5008.

[128] S. Yang, S. H. Lim, J. H. Hong, J. S. Park, J. Kim, and H. W. Kim, “Deep Learning-based Lung Cancer Risk Assessment Using Chest Computed Tomography Images Without Pulmonary Nodules >/= 8 Mm,” Translational Lung Cancer Research 14, no. 1 (2025): 150-162.

[129] Y. Jiang and V. S. K. Manem, “Data Augmented Lung Cancer Prediction Framework Using the Nested Case Control NLST Cohort,” Frontiers in Oncology 15 (2025): 1492758.

[130] J. Simon, P. Mikhael, A. Graur, et al., “Significance of Image Reconstruction Parameters for Future Lung Cancer Risk Prediction Using Low-Dose Chest Computed Tomography and the Open-Access Sybil Algorithm,” Investigative Radiology 60, no. 5 (2025): 311-318.

[131] Y. Wang, A. Gupta, F. I. Tushar, et al., “Concordance-based Predictive Uncertainty (CPU)-Index: Proof-of-concept With Application towards Improved Specificity of Lung Cancers on Low Dose Screening CT,” Artificial Intelligence in Medicine 160 (2025): 103055.

[132] L. Meng, P. Zhu, and K. Xia, “Application Value of the Automated Machine Learning Model Based on Modified CT Index Combined With Serological Indices in the Early Prediction of Lung Cancer,” Frontiers in Public Health 12 (2024): 1368217.

[133] Y. Wang, C. Zhou, L. Ying, et al., “Enhancing Early Lung Cancer Diagnosis: Predicting Lung Nodule Progression in Follow-Up Low-Dose CT Scan With Deep Generative Model,” Cancers (Basel) 16, no. 12 (2024): 2229.

[134] I. Bhatia, A. S. I. Aarti, F. Amin, and A. Alabrah, “Lightweight Advanced Deep Neural Network (DNN) Model for Early-Stage Lung Cancer Detection,” Diagnostics (Basel) 14, no. 21 (2024): 2356.

[135] I. Bhatia, Aarti, S. I. Ansarullah, F. Amin, and A. Alabrah, “An Advanced Lung Carcinoma Prediction and Risk Screening Model Using Transfer Learning,” Diagnostics (Basel) 14, no. 13 (2024): 1378.

[136] R. R. Shivwanshi and N. Nirala, “Hyperparameter Optimization and Development of an Advanced CNN-based Technique for Lung Nodule Assessment,” Physics in Medicine and Biology 68, no. 17 (2023): 175038.

[137] M. Wang, Z. Yang, and R. Zhao, “Advancing Lung Cancer Diagnosis: Combining 3D Auto-encoders and Attention Mechanisms for CT Scan Analysis,” Journal of X-Ray Science and Technology 33, no. 2 (2025): 376-392.

[138] H. H. Chang, C. Z. Wu, and A. H. Gallogly, “Pulmonary Nodule Classification Using a Multiview Residual Selective Kernel Network,” Journal of Imaging Informatics in Medicine 37, no. 1 (2024): 347-362.

[139] Y. Hussain Ali, V. Sabu Chooralil, K. Balasubramanian, et al., “Optimization System Based on Convolutional Neural Network and Internet of Medical Things for Early Diagnosis of Lung Cancer,” Bioengineering (Basel) 10, no. 3 (2023): 320.

[140] L. Ma, C. Wan, K. Hao, A. Cai, and L. Liu, “A Novel Fusion Algorithm for Benign-malignant Lung Nodule Classification on CT Images,” BMC Pulmonary Medicine 23, no. 1 (2023): 474.

[141] J. R. Tugwell-Allsup, B. W. Owen, R. Hibbs, and A. England, “The Use of Artificial Intelligence to Aid the Diagnosis of Lung Cancer—A Retrospective-cohort Study,” Radiography (London) 31, no. 2 (2025): 102876.

[142] R. Hu, Y. Xie, L. Zhang, et al., “A Two-stage Deep-learning Framework for CT Denoising Based on a Clinically Structure-unaligned Paired Data Set,” Quantitative Imaging in Medicine and Surgery 14, no. 1 (2024): 335-351.

[143] S. Lam, M. W. Wynes, C. Connolly, et al., “The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative,” Journal of Thoracic Oncology 19, no. 1 (2024): 94-105.

[144] F. I. Tushar, L. Vancoillie, C. McCabe, et al., “Virtual Lung Screening Trial (VLST): An in Silico Study Inspired by the National Lung Screening Trial for Lung Cancer Detection,” Medical Image Analysis 103 (2025): 103576.

[145] Z. Gao, Z. Yu, X. Zhang, et al., “Development of a Deep Learning Model for Early Gastric Cancer Diagnosis Using Preoperative Computed Tomography Images,” Frontiers in Oncology 13 (2023): 1265366.

[146] C. Peng, P. L. H. Yu, J. Lu, et al., “Opportunistic Detection of Hepatocellular Carcinoma Using Noncontrast CT and Deep Learning Artificial Intelligence,” Journal of the American College of Radiology 22, no. 3 (2025): 249-259.

[147] E. Sahin, O. C. Tatar, M. E. Ulutas, et al., “Diagnostic Performance of Deep Learning Applications in Hepatocellular Carcinoma Detection Using Computed Tomography Imaging,” The Turkish Journal of Gastroenterology: The Official Journal of Turkish Society of Gastroenterology 36, no. 2 (2024): 124-130.

[148] L. Li, T. Liu, P. Wang, et al., “Multiple Perception Contrastive Learning for Automated Ovarian Tumor Classification in CT Images,” Abdominal Radiology (NY) 50, no. 9 (2025): 4342-4358.

[149] S. Amiri, R. Karimzadeh, T. Vrtovec, et al., “Centerline-guided Reinforcement Learning Model for Pancreatic Duct Identifications,” Journal of Medical Imaging (Bellingham) 11, no. 6 (2024): 064002.

[150] Y. Shi, H. Tang, M. J. Baine, et al., “3DGAUnet: 3D Generative Adversarial Networks With a 3D U-Net Based Generator to Achieve the Accurate and Effective Synthesis of Clinical Tumor Image Data for Pancreatic Cancer,” Cancers (Basel) 15, no. 23 (2023): 5496.

[151] S. Mandal, K. Balraj, H. Kodamana, et al., “Weakly Supervised Large-scale Pancreatic Cancer Detection Using Multi-instance Learning,” Frontiers in Oncology 14 (2024): 1362850.

[152] C. Abi Nader, R. Vetil, L. K. Wood, et al., “Automatic Detection of Pancreatic Lesions and Main Pancreatic Duct Dilatation on Portal Venous CT Scans Using Deep Learning,” Investigative Radiology 58, no. 11 (2023): 791-798.

[153] M. Ramaekers, C. G. A. Viviers, T. A. E. Hellstrom, et al., “Improved Pancreatic Cancer Detection and Localization on CT Scans: A Computer-Aided Detection Model Utilizing Secondary Features,” Cancers (Basel) 16, no. 13 (2024): 2403.

[154] Y. Alaca, “Machine Learning via DARTS-Optimized MobileViT Models for Pancreatic Cancer Diagnosis With Graph-based Deep Learning,” BMC Medical Informatics and Decision Making [Electronic Resource] 25, no. 1 (2025): 81.

[155] A. Nadeem, R. Ashraf, T. Mahmood, and S. Parveen, “Automated CAD System for Early Detection and Classification of Pancreatic Cancer Using Deep Learning Model,” PLoS ONE 20, no. 1 (2025): e0307900.

[156] A. S. Minhas and R. Oliver, “Magnetic Resonance Imaging Basics,” Advances in Experimental Medicine and Biology 1380 (2022): 47-82.

[157] M. C. Florkow, K. Willemsen, V. V. Mascarenhas, E. H. G. Oei, M. van Stralen, and P. R. Seevinck, “Magnetic Resonance Imaging versus Computed Tomography for Three-Dimensional Bone Imaging of Musculoskeletal Pathologies: A Review,” Journal of Magnetic Resonance Imaging 56, no. 1 (2022): 11-34.

[158] J. N. C. Raimundo, J. P. P. Fontes, L. Gonzaga Mendes Magalhaes, and M. A. Guevara Lopez, “An Innovative Faster R-CNN-Based Framework for Breast Cancer Detection in MRI,” Journal of Imaging 9, no. 9 (2023): 169.

[159] C. Sahaya Pushpa Sarmila Star, T. M. Inbamalar, and A. Milton, “Segmentation of Breast Lesion Using Fuzzy Thresholding and Deep Learning,” Computers in Biology and Medicine 184 (2025): 109406.

[160] J. Ouyang, K. T. Chen, R. Duarte Armindo, G. A. Davidzon, K. E. Hawk, and F. Moradi, “Predicting FDG-PET Images from Multi-Contrast MRI Using Deep Learning in Patients with Brain Neoplasms,” Journal of Magnetic Resonance Imaging 59, no. 3 (2024): 1010-1020.

[161] M. Ariful Islam, M. F. Mridha, M. Safran, S. Alfarhood, and M. Mohsin Kabir, “Revolutionizing Brain Tumor Detection Using Explainable AI in MRI Images,” NMR in Biomedicine 38, no. 3 (2025): e70001.

[162] M. Cheng, H. Zhang, Y. Guo, et al., “Comparison of MRI and CT Based Deep Learning Radiomics Analyses and Their Combination for Diagnosing Intrahepatic Cholangiocarcinoma,” Scientific Reports 15, no. 1 (2025): 9629.

[163] S. Ziegelmayer, A. W. Marka, M. Strenzke, et al., “Speed and Efficiency: Evaluating Pulmonary Nodule Detection With AI-enhanced 3D Gradient Echo Imaging,” European Radiology 35, no. 4 (2025): 2237-2244.

[164] Y. Yuan, E. Ahn, D. Feng, M. Khadra, and J. Kim, “Z-SSMNet: Zonal-aware Self-supervised Mesh Network for Prostate Cancer Detection and Diagnosis With Bi-parametric MRI,” Computerized Medical Imaging and Graphics 122 (2025): 102510.

[165] T. Chen, W. Hu, Y. Zhang, et al., “A Multimodal Deep Learning Nomogram for the Identification of Clinically Significant Prostate Cancer in Patients With Gray-Zone PSA Levels: Comparison With Clinical and Radiomics Models,” Academic Radiology 32, no. 2 (2025): 864-876.

[166] H. Huang, J. Mo, Z. Ding, et al., “Deep Learning to Simulate Contrast-Enhanced MRI for Evaluating Suspected Prostate Cancer,” Radiology 314, no. 1 (2025): e240238.

[167] Y. J. Lee, H. W. Moon, M. H. Choi, S. Eun Jung, Y. H. Park, and J. Y. Lee, “MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study,” Radiology 314, no. 3 (2025): e232788.

[168] L. M. Esteban, A. Borque-Fernando, M. E. Escorihuela, J. Esteban-Escano, J. M. Abascal, and P. Servian, “Integrating Radiological and Clinical Data for Clinically Significant Prostate Cancer Detection With Machine Learning Techniques,” Scientific Reports 15, no. 1 (2025): 4261.

[169] M. Chondronikola and S. Sarkar, “Total-body PET Imaging: A New Frontier for the Assessment of Metabolic Disease and Obesity,” PET Clinics 16, no. 1 (2021): 75-87.

[170] X. Li, B. Pan, C. Chen, et al., “Clinical Evaluation of Deep Learning-enhanced Lymphoma Pet Imaging With Accelerated Acquisition,” Journal of Applied Clinical Medical Physics [Electronic Resource] 25, no. 9 (2024): e14390.

[171] T. Yang, D. Liu, Z. Zhang, R. Sa, and F. Guan, “Predicting T-Cell Lymphoma in Children from (18)F-FDG PET-CT Imaging with Multiple Machine Learning Models,” Journal of Imaging Informatics in Medicine 37, no. 3 (2024): 952-964.

[172] P. Guan, K. Yu, W. Wei, Y. Tan, and J. Wu, “Big Data Analytics on Lung Cancer Diagnosis Framework with Deep Learning,” IEEE Transactions on Computational Biology and Bioinformatics 21, no. 4 (2024): 757-768.

[173] P. Shyamala Bharathi and C. Shalini, “Advanced Hybrid Attention-based Deep Learning Network With Heuristic Algorithm for Adaptive CT and PET Image Fusion in Lung Cancer Detection,” Medical Engineering & Physics 126 (2024): 104138.

[174] C. Jiang, C. Qian, Q. Jiang, et al., “Virtual Biopsy for Non-invasive Identification of Follicular Lymphoma Histologic Transformation Using Radiomics-based Imaging Biomarker From PET/CT,” BMC Medicine [Electronic Resource] 23, no. 1 (2025): 49.

[175] A. Soliman, Z. Li, and A. V. Parwani, “Artificial Intelligence's Impact on Breast Cancer Pathology: A Literature Review,” Diagnostic Pathology 19, no. 1 (2024): 38.

[176] K. Lami, H. S. Yoon, A. V. Parwani, et al., “Validation of Prostate and Breast Cancer Detection Artificial Intelligence Algorithms for Accurate Histopathological Diagnosis and Grading: A Retrospective Study With a Japanese Cohort,” Pathology 56, no. 5 (2024): 633-642.

[177] J. Sandbank, G. Bataillon, A. Nudelman, et al., “Validation and Real-world Clinical Application of an Artificial Intelligence Algorithm for Breast Cancer Detection in Biopsies,” NPJ Breast Cancer 8, no. 1 (2022): 129.

[178] S. Ahuja and S. Zaheer, “Advancements in Pathology: Digital Transformation, Precision Medicine, and Beyond,” Journal of Pathology Informatics 16 (2025): 100408.

[179] B. Challa, M. Tahir, Y. Hu, et al., “Artificial Intelligence-Aided Diagnosis of Breast Cancer Lymph Node Metastasis on Histologic Slides in a Digital Workflow,” Modern Pathology 36, no. 8 (2023): 100216.

[180] C. Eloy, A. Marques, J. Pinto, et al., “Artificial Intelligence-assisted Cancer Diagnosis Improves the Efficiency of Pathologists in Prostatic Biopsies,” Virchows Archiv 482, no. 3 (2023): 595-604.

[181] R. Pannala, K. Krishnan, J. Melson, et al., “Artificial Intelligence in Gastrointestinal Endoscopy,” VideoGIE 5, no. 12 (2020): 598-613.

[182] P. Sanga, J. Singh, A. K. Dubey, et al., “DermAI 1.0: A Robust, Generalized, and Novel Attention-Enabled Ensemble-Based Transfer Learning Paradigm for Multiclass Classification of Skin Lesion Images,” Diagnostics (Basel) 13, no. 19 (2023): 3159.

[183] X. Matias-Guiu, G. Stanta, F. Carneiro, et al., “The Leading Role of Pathology in Assessing the Somatic Molecular Alterations of Cancer: Position Paper of the European Society of Pathology,” Virchows Archiv 476, no. 4 (2020): 491-497.

[184] I. Kim, K. Kang, Y. Song, and T. J. Kim, “Application of Artificial Intelligence in Pathology: Trends and Challenges,” Diagnostics (Basel) 12, no. 11 (2022): 2794.

[185] Z. Ahmad, S. Rahim, M. Zubair, and J. Abdul-Ghafar, “Artificial Intelligence (AI) in Medicine, Current Applications and Future Role With Special Emphasis on Its Potential and Promise in Pathology: Present and Future Impact, Obstacles Including Costs and Acceptance Among Pathologists, Practical and Philosophical Considerations. A Comprehensive Review,” Diagnostic Pathology 16, no. 1 (2021): 24.

[186] B. Huang, F. Yang, M. Yin, X. Mo, and C. Zhong, “A Review of Multimodal Medical Image Fusion Techniques,” Computational and Mathematical Methods in Medicine 2020 (2020): 8279342.

[187] Z. Liu, Y. Wu, H. Xu, et al., “Multimodal Fusion of Radio-pathology and Proteogenomics Identify Integrated Glioma Subtypes With Prognostic and Therapeutic Opportunities,” Nature Communications 16, no. 1 (2025): 3510.

[188] B. Lokaj, V. Durand de Gevigney, D. A. Djema, et al., “Multimodal Deep Learning Fusion of Ultrafast-DCE MRI and Clinical Information for Breast Lesion Classification,” Computers in Biology and Medicine 188 (2025): 109721.

[189] M. Li, Y. Fang, J. Shao, et al., “Vision Transformer-based Multimodal Fusion Network for Classification of Tumor Malignancy on Breast Ultrasound: A Retrospective Multicenter Study,” International Journal of Medical Informatics 196 (2025): 105793.

[190] Y. Cho, S. Misra, R. Managuli, R. G. Barr, J. Lee, and C. Kim, “Attention-based Fusion Network for Breast Cancer Segmentation and Classification Using Multi-modal Ultrasound Images,” Ultrasound in Medicine & Biology 51, no. 3 (2025): 568-577.

[191] S. Shirae, S. S. Debsarkar, H. Kawanaka, B. Aronow, and V. B. S. Prasath, “Multimodal Ensemble Fusion Deep Learning Using Histopathological Images and Clinical Data for Glioma Subtype Classification,” IEEE Access 13 (2025): 57780-57797.

[192] H. Xu and R. Lv, “Rapid Diagnosis of Lung Cancer by Multi-modal Spectral Data Combined With Deep Learning,” Spectrochimica Acta Part A, Molecular and Biomolecular Spectroscopy 335 (2025): 125997.

[193] S. J. H. Shah, A. Albishri, R. Wang, and Y. Lee, “Integrating Local and Global Attention Mechanisms for Enhanced Oral Cancer Detection and Explainability,” Computers in Biology and Medicine 189 (2025): 109841.

[194] Y. Wang, S. Chi, Y. Tian, et al., “Construction of an Artificially Intelligent Model for Accurate Detection of HCC by Integrating Clinical, Radiological, and Peripheral Immunological Features,” International Journal of Surgery 111, no. 4 (2025): 2942-2952.

[195] S. Cabon, S. Brihi, R. Fezzani, M. Pierre-Jean, M. Cuggia, and G. Bouzille, “Combining a Risk Factor Score Designed from Electronic Health Records with a Digital Cytology Image Scoring System to Improve Bladder Cancer Detection: Proof-of-Concept Study,” Journal of Medical Internet Research [Electronic Resource] 27 (2025): e56946.

[196] H. Yang, M. Yang, J. Chen, G. Yao, Q. Zou, and L. Jia, “Multimodal Deep Learning Approaches for Precision Oncology: A Comprehensive Review,” Briefings in Bioinformatics 26, no. 1 (2024): bbae699.

[197] B. P. Cabral, L. A. M. Braga, S. Syed-Abdul, and F. B. Mota, “Future of Artificial Intelligence Applications in Cancer Care: A Global Cross-Sectional Survey of Researchers,” Current Oncology 30, no. 3 (2023): 3432-3446.

[198] D. Capper, D. T. W. Jones, M. Sill, et al., “DNA Methylation-based Classification of central Nervous System Tumours,” Nature 555, no. 7697 (2018): 469-474.

[199] S. Benfatto, M. Sill, D. T. W. Jones, et al., “Explainable Artificial Intelligence of DNA Methylation-based Brain Tumor Diagnostics,” Nature Communications 16, no. 1 (2025): 1787.

[200] J. Shen, L. Lu, Z. Chen, et al., “Multi-omics Analysis Constructs a Novel Neuroendocrine Prostate Cancer Classifier and Classification System,” Scientific Reports 15, no. 1 (2025): 13901.

[201] A. A. Alzahrani, J. Alsamri, M. Maashi, et al., “Deep Structured Learning With Vision Intelligence for Oral Carcinoma Lesion Segmentation and Classification Using Medical Imaging,” Scientific Reports 15, no. 1 (2025): 6610.

[202] K. Lakshmi, S. Amaran, G. Subbulakshmi, S. Padmini, G. P. Joshi, and W. Cho, “Explainable Artificial Intelligence With UNet Based Segmentation and Bayesian Machine Learning for Classification of Brain Tumors Using MRI Images,” Scientific Reports 15, no. 1 (2025): 690.

[203] E. Hassan and H. Ghadiri, “Advancing Brain Tumor Classification: A Robust Framework Using EfficientNetV2 Transfer Learning and Statistical Analysis,” Computers in Biology and Medicine 185 (2025): 109542.

[204] V. Satushe, V. Vyas, S. Metkar, and D. Paul Singh, “Advanced CNN Architecture for Brain Tumor Segmentation and Classification Using BraTS-GOAT 2024 Dataset,” Current Medical Imaging 21 (2025): e15734056344235.

[205] S. Abirami, K. Ramesh, and K. Lalitha VaniSree, “Classification and Pixel Change Detection of Brain Tumor Using Adam Kookaburra Optimization-Based Shepard Convolutional Neural Network,” Nmr in Biomedicine 38, no. 2 (2025): e5307.

[206] Y. Mao, J. Kim, L. Podina, and M. Kohandel, “Dilated SE-DenseNet for Brain Tumor MRI Classification,” Scientific Reports 15, no. 1 (2025): 3596.

[207] S. Ganesh, R. Gomathi, and S. Kannadhasan, “Brain Tumor Segmentation and Detection in MRI Using Convolutional Neural Networks and VGG16,” Cancer Biomarkers 42, no. 3 (2025): 18758592241311184.

[208] K. A. Huang, A. Alkadri, and N. Prakash, “Employing Squeeze-and-Excitation Architecture in a Fine-Tuned Convolutional Neural Network for Magnetic Resonance Imaging Tumor Classification,” Cureus 17, no. 3 (2025): e80084.

[209] M. A. Ilani, D. Shi, and Y. M. Banad, “T1-weighted MRI-based Brain Tumor Classification Using Hybrid Deep Learning Models,” Scientific Reports 15, no. 1 (2025): 7010.

[210] P. Jyothi and S. Dhanasekaran, “An Attention 3DUNET and Visual Geometry Group-19 Based Deep Neural Network for Brain Tumor Segmentation and Classification From MRI,” Journal of Biomolecular Structure & Dynamics 43, no. 2 (2025): 730-741.

[211] K. Pugazharasi and K. Sakthivel, “Enhanced Glioma Tumor Detection and Segmentation Using Modified Deep Learning With Edge Fusion and Frequency Features,” Scientific Reports 15, no. 1 (2025): 6899.

[212] M. Kaddes, Y. M. Ayid, A. M. Elshewey, and Y. Fouad, “Breast Cancer Classification Based on Hybrid CNN With LSTM Model,” Scientific Reports 15, no. 1 (2025): 4409.

[213] G. G. Lakshmi and P. Nagaraj, “Lung Cancer Detection and Classification Using Optimized CNN Features and Squeeze-Inception-ResNeXt Model,” Computational Biology and Chemistry 117 (2025): 108437.

[214] R. Tanaka, Y. Tsuboshita, M. Okodo, et al., “Artificial Intelligence Recognition Model Using Liquid-Based Cytology Images to Discriminate Malignancy and Histological Types of Non-Small-Cell Lung Cancer,” Pathobiology 92, no. 1 (2025): 52-62.

[215] V. P. Gladis Pushparathi, D. Justin Xavier, P. Chitra, and G. Kannan, “Prostate Cancer Classification and Interpretation with Multiparametric Magnetic Resonance Imaging and Gleason Grade Score Using DarkNet53 Model,” Prostate 85, no. 3 (2025): 294-307.

[216] J. H. Han, B. W. Kim, T. M. Kim, et al., “Fully Automated Segmentation and Classification of Renal Tumors on CT Scans via Machine Learning,” BMC Cancer 25, no. 1 (2025): 173.

[217] H. Guo, J. Zhang, Y. Li, X. Pan, and C. Sun, “Advanced Pathological Subtype Classification of Thyroid Cancer Using efficientNetB0,” Diagnostic Pathology 20, no. 1 (2025): 28.

[218] P. Bedi, S. Rani, B. Gupta, V. Bhasin, and P. Gole, “EpiBrCan-Lite: A Lightweight Deep Learning Model for Breast Cancer Subtype Classification Using Epigenomic Data,” Computer Methods and Programs in Biomedicine 260 (2025): 108553.

[219] K. Borah, H. S. Das, R. K. Budhathoki, K. Aurangzeb, and S. Mallik, “DOMSCNet: A Deep Learning Model for the Classification of Stomach Cancer Using Multi-layer Omics Data,” Briefings in Bioinformatics 26, no. 2 (2025): bbaf115.

[220] L. Yin and J. Wang, “Enhancing Brain Tumor Classification by Integrating Radiomics and Deep Learning Features: A Comprehensive Study Utilizing Ensemble Methods on MRI Scans,” Journal of X-Ray Science and Technology 33, no. 1 (2025): 47-57.

[221] D. Li, W. Hu, L. Ma, et al., “Deep Learning Radiomics Nomograms Predict Isocitrate Dehydrogenase (IDH) Genotypes in Brain Glioma: A Multicenter Study,” Magnetic Resonance Imaging 117 (2025): 110314.

[222] Y. Zeng, Y. Zhang, Z. Xiao, and H. Sui, “A Multi-classification Deep Neural Network for Cancer Type Identification From High-dimension, Small-sample and Imbalanced Gene Microarray Data,” Scientific Reports 15, no. 1 (2025): 5239.

[223] D. Kawahara, M. Kishi, Y. Kadooka, K. Hirose, and Y. Murakami, “Integrating Radiomics and Gene Expression by Mapping on the Image With Improved DeepInsight for Clear Cell Renal Cell Carcinoma,” Cancer Genetics 292-293 (2025): 100-105.

[224] B. Zhang, J. Zhu, R. Xu, et al., “A Combined Model Integrating Radiomics and Deep Learning Based on Multiparametric Magnetic Resonance Imaging for Classification of Brain Metastases,” Acta Radiologica 66, no. 1 (2025): 24-34.

[225] D. Bertsimas, G. A. Margonis, S. Sujichantararat, et al., “Interpretable Artificial Intelligence to Optimise Use of imatinib After Resection in Patients With Localised Gastrointestinal Stromal Tumours: An Observational Cohort Study,” The Lancet Oncology 25, no. 8 (2024): 1025-1037.

[226] Z. Wang, D. N. Chen, X. Y. Huang, et al., “Machine Learning-based Autophagy-related Prognostic Signature for Personalized Risk Stratification and Therapeutic Approaches in Bladder Cancer,” International Immunopharmacology 138 (2024): 112623.

[227] D. Chatziisaak, P. Burri, M. Sparn, D. Hahnloser, T. Steffen, and S. Bischofberger, “Concordance of ChatGPT Artificial Intelligence Decision-making in Colorectal Cancer Multidisciplinary Meetings: Retrospective Study,” BJS Open 9, no. 3 (2025): zraf040.

[228] H. M. Kim, S. S. Byun, J. K. Kim, et al., “Machine Learning-based Prediction Model for Late Recurrence After Surgery in Patients With Renal Cell Carcinoma,” BMC Medical Informatics and Decision Making [Electronic Resource] 22, no. 1 (2022): 241.

[229] W. H. Song and M. Park, “RCC-Supporter: Supporting Renal Cell Carcinoma Treatment Decision-making Using Machine Learning,” BMC Medical Informatics and Decision Making [Electronic Resource] 24, no. Suppl 2 (2024): 259.

[230] R. M. Gomez Del Moral Herranz, M. J. Lopez Rodriguez, A. P. Seiffert, J. Soto Perez-Olivares, M. Chiva De Agustin, and P. Sanchez-Gonzalez, “CureMate: A Clinical Decision Support System for Breast Cancer Treatment,” International Journal of Medical Informatics 192 (2024): 105647.

[231] G. H. Choi, J. Yun, J. Choi, et al., “Development of Machine Learning-based Clinical Decision Support System for Hepatocellular Carcinoma,” Scientific Reports 10, no. 1 (2020): 14855.

[232] X. Liang, R. Guan, J. Zhu, et al., “A Clinical Decision Support System to Predict the Efficacy for EGFR-TKIs Based on Artificial Neural Network,” Journal of Cancer Research and Clinical Oncology 149, no. 13 (2023): 12265-12274.

[233] G. Valdes, C. B. Simone, J. Chen, et al., “Clinical Decision Support of Radiotherapy Treatment Planning: A Data-driven Machine Learning Strategy for Patient-specific Dosimetric Decision Making,” Radiotherapy and Oncology 125, no. 3 (2017): 392-397.

[234] W. Li, Y. H. Huang, T. Zhu, et al., “Noninvasive Artificial Intelligence System for Early Predicting Residual Cancer Burden during Neoadjuvant Chemotherapy in Breast Cancer,” Annals of Surgery 281, no. 4 (2025): 645-654.

[235] M. H. A. Janse, L. M. Janssen, B. H. M. van der Velden, et al., “Deep Learning-Based Segmentation of Locally Advanced Breast Cancer on MRI in Relation to Residual Cancer Burden: A Multi-Institutional Cohort Study,” Journal of Magnetic Resonance Imaging 58, no. 6 (2023): 1739-1749.

[236] A. J. Widman, M. Shah, A. Frydendahl, et al., “Ultrasensitive Plasma-based Monitoring of Tumor Burden Using Machine-learning-guided Signal Enrichment,” Nature Medicine 30, no. 6 (2024): 1655-1666.

[237] D. Grama, M. Dahele, B. Slotman, and W. Verbakel, “Explainable AI for Raising Confidence in Deep Learning-based Tumor Tracking Models,” Medical Physics 52, no. 7 (2025): e17940.

[238] Y. H. Huang, Z. Y. Shi, T. Zhu, et al., “Longitudinal MRI-Driven Multi-Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer,” Advanced Science (Weinheim) 12, no. 12 (2025): e2413702.

[239] M. C. Comes, A. Fanizzi, S. Bove, et al., “Monitoring over Time of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients through an Ensemble Vision Transformers-Based Model,” Cancer Medicine 13, no. 24 (2024): e70482.

[240] M. Gilad, S. C. Partridge, M. Iima, R. R. Md, and M. Freiman, “Radiomics-based Machine Learning Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Using Physiologically Decomposed Diffusion-weighted MRI,” Radiology Imaging Cancer 7, no. 4 (2025): e240312.

[241] Z. Zhang, T. Luo, M. Yan, et al., “Voxel-level Radiomics and Deep Learning for Predicting Pathologic Complete Response in Esophageal Squamous Cell Carcinoma After Neoadjuvant Immunotherapy and Chemotherapy,” Journal for ImmunoTherapy of Cancer 13, no. 3 (2025): e011149.

[242] H. Shen, Z. Jin, Q. Chen, et al., “Image-based Artificial Intelligence for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Systematic Review and Meta-analysis,” Radiologia Medica 129, no. 4 (2024): 598-614.

[243] E. Domingo, S. Rathee, A. Blake, et al., “Identification and Validation of a Machine Learning Model of Complete Response to Radiation in Rectal Cancer Reveals Immune Infiltrate and TGFbeta as Key Predictors,” EBioMedicine 106 (2024): 105228.

[244] Y. Wang, Z. Pan, S. Li, et al., “Prediction and Validation of Pathologic Complete Response for Locally Advanced Rectal Cancer Under Neoadjuvant Chemoradiotherapy Based on a Novel Predictor Using Interpretable Machine Learning,” European Journal of Surgical Oncology 50, no. 12 (2024): 108738.

[245] X. Jin, X. Zheng, D. Chen, J. Jin, G. Zhu, and X. Deng, “Prediction of Response After Chemoradiation for Esophageal Cancer Using a Combination of Dosimetry and CT Radiomics,” European Radiology 29, no. 11 (2019): 6080-6088.

[246] Z. Cai, S. Li, Z. Xiong, J. Lin, and Y. Sun, “Multimodal MRI-based Deep-radiomics Model Predicts Response in Cervical Cancer Treated With Neoadjuvant Chemoradiotherapy,” Scientific Reports 14, no. 1 (2024): 19090.

[247] G. Macchia, S. Cilla, D. Pezzulla, et al., “Efficacy of Stereotactic Body Radiotherapy and Response Prediction Using Artificial Intelligence in Oligometastatic Gynaecologic Cancer,” Gynecologic Oncology 184 (2024): 16-23.

[248] A. Kedves, M. Akay, Y. Akay, et al., “Predictive Value of Magnetic Resonance Imaging Diffusion Parameters Using Artificial Intelligence in Low-and Intermediate-risk Prostate Cancer Patients Treated With Stereotactic Ablative Radiotherapy: A Pilot Study,” Radiography (London) 30, no. 3 (2024): 986-994.

[249] P. Johannet, N. Coudray, D. M. Donnelly, G. Jour, I. Illa-Bochaca, and Y. Xia, “Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients With Advanced Melanoma,” Clinical Cancer Research 27, no. 1 (2021): 131-140.

[250] Y. Jiang, K. Zhou, Z. Sun, et al., “Non-invasive Tumor Microenvironment Evaluation and Treatment Response Prediction in Gastric Cancer Using Deep Learning Radiomics,” Cell Reports Medicine 4, no. 8 (2023): 101146.

[251] Q. Sun, T. Li, Z. Wei, Z. Ye, X. Zhao, and J. Jing, “Integrating Transcriptomic Data and Digital Pathology for NRG-based Prediction of Prognosis and Therapy Response in Gastric Cancer,” Annals of Medicine 56, no. 1 (2024): 2426758.

[252] Z. Lin, W. Wang, Y. Yan, Z. Ma, Z. Xiao, and K. Mao, “A Deep Learning-based Clinical-radiomics Model Predicting the Treatment Response of Immune Checkpoint Inhibitors (ICIs)-based Conversion Therapy in Potentially Convertible Hepatocelluar Carcinoma Patients: A Tumor Marker Prognostic Study,” International Journal of Surgery 111, no. 5 (2025): 3342-3355.

[253] K. C. Arbour, A. T. Luu, J. Luo, et al., “Deep Learning to Estimate RECIST in Patients With NSCLC Treated With PD-1 Blockade,” Cancer Discovery 11, no. 1 (2021): 59-67.

[254] X. Wang, L. Yang, C. Yu, et al., “An Integrated Computational Strategy to Predict Personalized Cancer Drug Combinations by Reversing Drug Resistance Signatures,” Computers in Biology and Medicine 163 (2023): 107230.

[255] S. Park, E. Silva, A. Singhal, et al., “A Deep Learning Model of Tumor Cell Architecture Elucidates Response and Resistance to CDK4/6 Inhibitors,” Nature Cancer 5, no. 7 (2024): 996-1009.

[256] H. Yan, X. Ji, and B. Li, “Advancing Personalized, Predictive, and Preventive Medicine in Bladder Cancer: A Multi-omics and Machine Learning Approach for Novel Prognostic Modeling, Immune Profiling, and Therapeutic Target Discovery,” Frontiers in Immunology 16 (2025): 1572034.

[257] S. Wang, H. Yu, Y. Gan, et al., “Mining Whole-lung Information by Artificial Intelligence for Predicting EGFR Genotype and Targeted Therapy Response in Lung Cancer: A Multicohort Study,” Lancet Digital Health 4, no. 5 (2022): e309-e319.

[258] T. Tang, Z. Zhou, M. Chen, et al., “Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial,” Clinical Cancer Research 30, no. 14 (2024): 2925-2936.

[259] N. D. Maulding, J. Zou, W. Zhou, et al., “Transformer-based Modeling of Clonal Selection and Expression Dynamics Reveals Resistance Mechanisms in Breast Cancer,” NPJ Systems Biology and Applications 11, no. 1 (2025): 5.

[260] Y. Zhong, X. Chen, S. Wu, et al., “Deciphering Colorectal Cancer Radioresistance and Immune Microrenvironment: Unraveling the Role of EIF5A Through Single-cell RNA Sequencing and Machine Learning,” Frontiers in Immunology 15 (2024): 1466226.

[261] J. Wang, J. Feng, X. Chen, et al., “Integrated Multi-omics Analysis and Machine Learning Identify Hub Genes and Potential Mechanisms of Resistance to Immunotherapy in Gastric Cancer,” Aging (Albany NY) 16, no. 8 (2024): 7331-7356.

[262] C. Wu, G. Zhang, L. Wang, et al., “Spatial Proteomic Profiling Elucidates Immune Determinants of Neoadjuvant Chemo-immunotherapy in Esophageal Squamous Cell Carcinoma,” Oncogene 43, no. 37 (2024): 2751-2767.

[263] L. Gerratana, A. A. Davis, L. Foffano, et al., “Integrating Machine Learning-predicted Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) in Metastatic Breast Cancer: A Proof of Principle Study on Endocrine Resistance Profiling,” Cancer Letters 609 (2025): 217325.

[264] S. Sahni, B. Wang, D. Wu, et al., “A Machine Learning Model Reveals Expansive Downregulation of Ligand-receptor Interactions That Enhance Lymphocyte Infiltration in Melanoma With Developed Resistance to Immune Checkpoint Blockade,” Nature Communications 15, no. 1 (2024): 8867.

[265] G. Che, J. Yin, W. Wang, et al., “Circumventing Drug Resistance in Gastric Cancer: A Spatial Multi-omics Exploration of Chemo and Immuno-therapeutic Response Dynamics,” Drug Resistance Updates 74 (2024): 101080.

[266] Q. Zhu, H. Dai, F. Qiu, et al., “Heterogeneity of Computational Pathomic Signature Predicts Drug Resistance and Intra-tumor Heterogeneity of Ovarian Cancer,” Translational Oncology 40 (2024): 101855.

[267] D. Zeng, Y. Yu, W. Qiu, et al., “Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer,” Advanced Science (Weinheim) 12, no. 25 (2025): e2417593.

[268] H. Wang, Y. Yang, J. Zhang, et al., “Integrating Single-cell RNA Sequencing and Artificial Intelligence for Multitargeted Drug Design for Combating Resistance in Liver Cancer,” NPJ Precision Oncology 9, no. 1 (2025): 309.

[269] A. Singh, A. Miranda Bedate, H. J. von Richthofen, et al., “A Novel Bioinformatics Pipeline for the Identification of Immune Inhibitory Receptors as Potential Therapeutic Targets,” Elife 13 (2024): RP92870.

[270] L. Zhao, H. Han, X. Zhou, et al., “Integrating Bulk and Single-Cell Transcriptomics With Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance,” International Journal of Molecular Sciences 26, no. 10 (2025): 4685.

[271] N. Tavakoli, E. J. Fong, A. Coleman, et al., “Merging Metabolic Modeling and Imaging for Screening Therapeutic Targets in Colorectal Cancer,” NPJ Systems Biology and Applications 11, no. 1 (2025): 12.

[272] Y. Chen, L. He, A. Ianevski, et al., “A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia,” Cancer Research 85, no. 14 (2025): 2753-2768.

[273] Z. Chen, Y. Chen, Y. Sun, et al., “Predicting Gastric Cancer Response to Anti-HER2 Therapy or Anti-HER2 Combined Immunotherapy Based on Multi-modal Data,” Signal Transduction and Targeted Therapy 9, no. 1 (2024): 222.

[274] S. A. Brown, B. Y. Chung, K. Doshi, et al., “Patient Similarity and Other Artificial Intelligence Machine Learning Algorithms in Clinical Decision Aid for Shared Decision-making in the Prevention of Cardiovascular Toxicity (PACT): A Feasibility Trial Design,” Cardiooncology 9, no. 1 (2023): 7.

[275] F. Balazard, A. Bertaut, E. Bordet, et al., “Adjuvant Endocrine Therapy Uptake, Toxicity, Quality of Life, and Prediction of Early Discontinuation,” JNCI: Journal of the National Cancer Institute 115, no. 9 (2023): 1099-1108.

[276] T. Yamanaka, J. Ukita, D. Xue, et al., “Artificial Intelligence System for Predicting Hand-foot Skin Reaction Induced by Vascular Endothelial Growth Factor Receptor Inhibitors,” Scientific Reports 15, no. 1 (2025): 9843.

[277] E. M. Froicu, O. M. Oniciuc, V. A. Afrasanie, et al., “The Use of Artificial Intelligence in Predicting Chemotherapy-Induced Toxicities in Metastatic Colorectal Cancer: A Data-Driven Approach for Personalized Oncology,” Diagnostics (Basel) 14, no. 18 (2024): 2074.

[278] S. Y. Zhu, T. T. Yang, Y. Z. Zhao, Y. Sun, X. M. Zheng, and H. B. Xu, “Interpretable Machine Learning Model Predicting Immune Checkpoint Inhibitor-induced Hypothyroidism: A Retrospective Cohort Study,” Cancer Science 115, no. 11 (2024): 3767-3775.

[279] D. S. Smith, L. Lippenszky, M. L. LeNoue-Newton, et al., “Radiomics and Deep Learning Prediction of Immunotherapy-Induced Pneumonitis from Computed Tomography,” JCO Clinical Cancer Informatics 9 (2025): e2400198.

[280] Z. Zhang, Z. Wang, T. Luo, et al., “Computed Tomography and Radiation Dose Images-based Deep-learning Model for Predicting Radiation Pneumonitis in Lung Cancer Patients After Radiation Therapy,” Radiotherapy and Oncology 182 (2023): 109581.

[281] Y. Zeng, Y. Hu, L. Wang, et al., “Control of Dental Calculus Prevents Severe Radiation-Induced Oral Mucositis in Patients Undergoing Radiotherapy for Nasopharyngeal Carcinoma,” Radiotherapy and Oncology 207 (2025): 110872.

[282] N. Lin, F. Abbas-Aghababazadeh, J. Su, et al., “Development of Machine Learning Models for Predicting Radiation Dermatitis in Breast Cancer Patients Using Clinical Risk Factors, Patient-Reported Outcomes, and Serum Cytokine Biomarkers,” Clinical Breast Cancer 25, no. 5 (2025): e622-e634. e6.

[283] X. Jiang, H. Zhao, O. L. Saldanha, et al., “An MRI Deep Learning Model Predicts Outcome in Rectal Cancer,” Radiology 307, no. 5 (2023): e222223.

[284] E. Wulczyn, D. F. Steiner, M. Moran, et al., “Interpretable Survival Prediction for Colorectal Cancer Using Deep Learning,” NPJ Digital Medicine 4, no. 1 (2021): 71.

[285] D. Bychkov, N. Linder, R. Turkki, et al., “Deep Learning Based Tissue Analysis Predicts Outcome in Colorectal Cancer,” Scientific Reports 8, no. 1 (2018): 3395.

[286] Z. Wu, A. E. Trevino, E. Wu, K. Swanson, H. J. Kim, and H. B. D'Angio, “Graph Deep Learning for the Characterization of Tumour Microenvironments From Spatial Protein Profiles in Tissue Specimens,” Nature Biomedical Engineering 6, no. 12 (2022): 1435-1448.

[287] S. Foersch, C. Glasner, A. C. Woerl, et al., “Multistain Deep Learning for Prediction of Prognosis and Therapy Response in Colorectal Cancer,” Nature Medicine 29, no. 2 (2023): 430-439.

[288] J. Keyl, P. Keyl, G. Montavon, et al., “Decoding Pan-cancer Treatment Outcomes Using Multimodal Real-world Data and Explainable Artificial Intelligence,” Nature Cancer 6, no. 2 (2025): 307-322.

[289] J. Liao, Z. Xu, Y. Xie, et al., “Assessing Axillary Lymph Node Burden and Prognosis in cT1-T2 Stage Breast Cancer Using Machine Learning Methods: A Retrospective Dual-Institutional MRI Study,” Journal of Magnetic Resonance Imaging 61, no. 3 (2025): 1221-1231.

[290] H. Chen, Z. Wang, J. Shi, and J. Peng, “Integrating Mitochondrial and Lysosomal Gene Analysis for Breast Cancer Prognosis Using Machine Learning,” Scientific Reports 15, no. 1 (2025): 3320.

[291] H. Chen, M. Chen, C. Yang, T. Tang, W. Wang, and W. Xue, “Machine Learning Based Intratumor Heterogeneity Related Signature for Prognosis and Drug Sensitivity in Breast Cancer,” Scientific Reports 15, no. 1 (2025): 10828.

[292] A. H. Hounye, L. Xiong, and M. Hou, “Integrated Explainable Machine Learning and Multi-omics Analysis for Survival Prediction in Cancer With Immunotherapy Response,” Apoptosis 30, no. 1-2 (2025): 364-388.

[293] H. Lin, J. Hua, Z. Gong, et al., “Multimodal Radiopathological Integration for Prognosis and Prediction of Adjuvant Chemotherapy Benefit in Resectable Lung Adenocarcinoma: A Multicentre Study,” Cancer Letters 616 (2025): 217557.

[294] T. Luo, M. Yan, M. Zhou, A. Dekker, A. L. Appelt, and Y. Ji, “Improved Prognostication of Overall Survival After Radiotherapy in Lung Cancer Patients by an Interpretable Machine Learning Model Integrating Lung and Tumor Radiomics and Clinical Parameters,” Radiologia Medica 130, no. 1 (2025): 96-109.

[295] I. Seven, D. Bayram, H. Arslan, et al., “Predicting Hepatocellular Carcinoma Survival With Artificial Intelligence,” Scientific Reports 15, no. 1 (2025): 6226.

[296] Y. Xiao, S. Sun, N. Zheng, et al., “Development of PDAC Diagnosis and Prognosis Evaluation Models Based on Machine Learning,” BMC Cancer 25, no. 1 (2025): 512.

[297] L. Dai, K. Ye, G. Yao, et al., “Using Machine Learning for Predicting Cancer-specific Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: A SEER-based Study,” BMC Cancer 25, no. 1 (2025): 523.

[298] Q. Deng, S. Li, Y. Zhang, Y. Jia, and Y. Yang, “Development and Validation of Interpretable Machine Learning Models to Predict Distant Metastasis and Prognosis of Muscle-invasive Bladder Cancer Patients,” Scientific Reports 15, no. 1 (2025): 11795.

[299] H. Liu, L. Ying, X. Song, X. Xiang, and S. Wei, “Development of Metastasis and Survival Prediction Model of Luminal and Non-luminal Breast Cancer With Weakly Supervised Learning Based on Pathomics,” PeerJ 13 (2025): e18780.

[300] Y. Yu, L. Cao, B. Shen, et al., “Deep Learning Radiopathomics Models Based on Contrast-enhanced MRI and Pathologic Imaging for Predicting Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma,” Radiology Imaging Cancer 7, no. 2 (2025): e240213.

[301] Q. Li, W. Zhang, T. Liao, Y. Gao, Y. Zhang, and A. Jin, “An Artificial Intelligence-Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients With Papillary Thyroid Carcinoma,” Clinical Cancer Research 31, no. 1 (2025): 139-150.

[302] F. Y. Feng, M. R. Smith, F. Saad, et al., “Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men with Nonmetastatic Castration-Resistant Prostate Cancer,” JCO Precision Oncology 9 (2025): e2400653.

[303] J. H. Wang, M. P. Deek, A. A. Mendes, et al., “Validation of an Artificial Intelligence-based Prognostic Biomarker in Patients With Oligometastatic Castration-Sensitive Prostate Cancer,” Radiotherapy and Oncology 202 (2025): 110618.

[304] Y. Zhao, L. Li, S. Yuan, et al., “Artificial Intelligence-assisted RNA-binding Protein Signature for Prognostic Stratification and Therapeutic Guidance in Breast Cancer,” Frontiers in Immunology 16 (2025): 1583103.

[305] F. Tian, X. He, S. Wang, et al., “Integrating Single-cell Sequencing and Machine Learning to Uncover the Role of Mitophagy in Subtyping and Prognosis of Esophageal Cancer,” Apoptosis 30, no. 3-4 (2025): 1021-1041.

[306] J. Zhu, B. Xu, Z. Wu, Z. Yu, S. Ji, and J. Lian, “Integrative Analysis of semaphorins family Genes in Colorectal Cancer: Implications for Prognosis and Immunotherapy,” Frontiers in Immunology 16 (2025): 1536545.

[307] Y. Zhao, D. Xun, J. Chen, and X. Qi, “A Novel Machine Learning-based Immune Prognostic Signature for Improving Clinical Outcomes and Guiding Therapy in Colorectal Cancer: An Integrated Bioinformatics and Experimental Study,” BMC Cancer 25, no. 1 (2025): 65.

[308] Y. Liu, B. Bian, S. Chen, et al., “Identification and Validation of Four Serum Biomarkers with Optimal Diagnostic and Prognostic Potential for Gastric Cancer Based on Machine Learning Algorithms,” Cancer Medicine 14, no. 6 (2025): e70659.

[309] X. Yan, M. Wang, L. Ji, X. Li, and B. Gao, “Machine Learning and Molecular Subtyping Reveal the Impact of Diverse Patterns of Cell Death on the Prognosis and Treatment of Hepatocellular Carcinoma,” Computational Biology and Chemistry 115 (2025): 108360.

[310] X. Liu, X. Wang, J. Ren, et al., “Machine Learning Based Identification of an Amino Acid Metabolism Related Signature for Predicting Prognosis and Immune Microenvironment in Pancreatic Cancer,” BMC Cancer 25, no. 1 (2025): 6.

[311] M. Kuang, Y. Liu, H. Chen, G. Chen, T. Gao, and K. You, “Big Data Analysis and Machine Learning of the Role of Cuproptosis-related Long Non-coding RNAs (CuLncs) in the Prognosis and Immune Landscape of Ovarian Cancer,” Frontiers in Immunology 16 (2025): 1555782.

[312] C. Fan, Z. Huang, H. Xu, et al., “Machine Learning-based Identification of co-expressed Genes in Prostate Cancer and CRPC and Construction of Prognostic Models,” Scientific Reports 15, no. 1 (2025): 5679.

[313] J. Jiang, Y. C. Hu, N. Tyagi, et al., “Tumor-aware, Adversarial Domain Adaptation From CT to MRI for Lung Cancer Segmentation,” Medical Image Computing and Computer-Assisted Intervention 11071 (2018): 777-785.

[314] T. Wang, Y. Lei, Z. Tian, et al., “Deep Learning-based Image Quality Improvement for Low-dose Computed Tomography Simulation in Radiation Therapy,” Journal of Medical Imaging (Bellingham, Wash) 6, no. 4 (2019): 043504.

[315] C. Davatzikos, J. S. Barnholtz-Sloan, S. Bakas, et al., “AI-based Prognostic Imaging Biomarkers for Precision Neuro-oncology: The ReSPOND Consortium,” Neuro-Oncology 22, no. 6 (2020): 886-888.

[316] J. Lipkova, R. J. Chen, B. Chen, et al., “Artificial Intelligence for Multimodal Data Integration in Oncology,” Cancer Cell 40, no. 10 (2022): 1095-1110.

[317] M. Elhaddad and S. Hamam, “AI-Driven Clinical Decision Support Systems: An Ongoing Pursuit of Potential,” Cureus 16, no. 4 (2024): e57728.

[318] B. Zhang, H. Shi, and H. Wang, “Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment Selection: A Critical Approach,” Journal of Multidisciplinary Healthcare 16 (2023): 1779-1791.

[319] G. K. Savova, I. Danciu, F. Alamudun, et al., “Use of Natural Language Processing to Extract Clinical Cancer Phenotypes From Electronic Medical Records,” Cancer Research 79, no. 21 (2019): 5463-5470.

[320] V. Hernstrom, V. Josefsson, H. Sartor, et al., “Screening Performance and Characteristics of Breast Cancer Detected in the Mammography Screening With Artificial Intelligence Trial (MASAI): A Randomised, Controlled, Parallel-group, Non-inferiority, Single-blinded, Screening Accuracy Study,” Lancet Digital Health 7, no. 3 (2025): e175-e183.

[321] Y. Mitsuyama, H. Tatekawa, H. Takita, et al., “Comparative Analysis of GPT-4-based ChatGPT's Diagnostic Performance With Radiologists Using Real-world Radiology Reports of Brain Tumors,” European Radiology 35, no. 4 (2025): 1938-1947.

[322] K. Nawaz, A. Zanib, I. Shabir, et al., “Skin Cancer Detection Using Dermoscopic Images With Convolutional Neural Network,” Scientific Reports 15, no. 1 (2025): 7252.

[323] V. P. G. Pushparathi, J. Shajeena, T. Kamalam, and M. Revathi, “Early Colon Cancer Prediction From Histopathological Images Using Enhanced Deep Learning With Confidence Scoring,” Cancer Investigation 43, no. 3 (2025): 205-223.

[324] S. M. Reincke, C. Espinosa, P. Chung, T. James, E. Berson, and N. Aghaeepour, “Mitigation of Outcome Conflation in Predicting Patient Outcomes Using Electronic Health Records,” Journal of the American Medical Informatics Association 32, no. 5 (2025): 920-927.

[325] E. J. Gong, C. S. Bang, and J. J. Lee, “Edge Artificial Intelligence Device in Real-Time Endoscopy for Classification of Gastric Neoplasms: Development and Validation Study,” Biomimetics (Basel) 9, no. 12 (2024): 783.

[326] M. Sevilla-Ayensa, A. Perez-Arruti, M. Alberich-Inchausti, E. Larruscain-Sarasola, J. A. Gonzalez-Garcia, and J. A. Sistaga-Suarez, “Validation of Step Oncology, a Platform for Head and Neck Cancer Patients Support During and After Treatment: Preliminary Results,” European Archives of Oto-Rhino-Laryngology 282, no. 5 (2025): 2597-2605.

[327] N. Arjmandi, M. A. Mosleh-Shirazi, S. Mohebbi, et al., “Evaluating the Dosimetric Impact of Deep-learning-based Auto-segmentation in Prostate Cancer Radiotherapy: Insights Into Real-world Clinical Implementation and Inter-observer Variability,” Journal of Applied Clinical Medical Physics [Electronic Resource] 26, no. 3 (2025): e14569.

[328] C. Sako, C. Duan, K. Maresca, et al., “Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non-Small Cell Lung Cancer,” JCO Clinical Cancer Informatics 8 (2024): e2400133.

[329] E. Wegener, M. Ng, M. Guerrieri, et al., “A Multicentre Implementation Trial of an Artificial Intelligence-driven Biomarker to Inform Shared Decisions for Androgen Deprivation Therapy in Men Undergoing Prostate Radiotherapy: The ASTuTE Protocol,” BMC Cancer 25, no. 1 (2025): 250.

[330] Y. Yu, W. Ouyang, Y. Huang, et al., “Artificial Intelligence-based Multi-modal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma: A Retrospective Study,” International Journal of Surgery 111, no. 1 (2025): 839-856.

[331] X. Q. Zhang, Z. N. Huang, J. Wu, et al., “Machine Learning Prediction of Early Recurrence in Gastric Cancer: A Nationwide Real-World Study,” Annals of Surgical Oncology 32, no. 4 (2025): 2637-2650.

[332] C. Schukow, S. C. Smith, E. Landgrebe, et al., “Application of ChatGPT in Routine Diagnostic Pathology: Promises, Pitfalls, and Potential Future Directions,” Advances in Anatomic Pathology 31, no. 1 (2024): 15-21.

[333] A. Mohammed and R. Kora, “A Comprehensive Review on Ensemble Deep Learning: Opportunities and Challenges,” Journal of King Saud University—Computer and Information Sciences 35, no. 2 (2023): 757-774.

[334] R. P. Singh, G. L. Hom, M. D. Abramoff, J. P. Campbell, and M. F. Chiang, “Intelligence AAOTFoA. Current Challenges and Barriers to Real-World Artificial Intelligence Adoption for the Healthcare System, Provider, and the Patient,” Translational Vision Science & Technology 9, no. 2 (2020): 45.

[335] H. Hua, Y. Deng, J. Zhang, X. Zhou, T. Zhang, and B. L. Khoo, “AIEgen-deep: Deep Learning of Single AIEgen-imaging Pattern for Cancer Cell Discrimination and Preclinical Diagnosis,” Biosensors & Bioelectronics 253 (2024): 116086.

[336] M. Calvarese, E. Corbetta, J. Contreras, et al., “Endomicroscopic AI-driven Morphochemical Imaging and Fs-laser Ablation for Selective Tumor Identification and Selective Tissue Removal,” Science Advances 10, no. 50 (2024): eado9721.

[337] J. Rappaport, Q. Chen, T. McGuire, A. Daugherty-Lopes, and R. Goldszmid, “Machine Learning Approach to Assess Brain Metastatic Burden in Preclinical Models,” Methods in Cell Biology 190 (2024): 25-49.

[338] J. Rodrigues, A. Amin, S. Chandra, et al., “Machine Learning Enabled Photoacoustic Spectroscopy for Noninvasive Assessment of Breast Tumor Progression in Vivo: A Preclinical Study,” ACS Sensors 9, no. 2 (2024): 589-601.

[339] N. Fraunhoffer, P. Hammel, T. Conroy, et al., “Development and Validation of AI-assisted Transcriptomic Signatures to Personalize Adjuvant Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma,” Annals of Oncology 35, no. 9 (2024): 780-791.

[340] S. Benzekry, M. Mastri, C. Nicolo, and J. M. L. Ebos, “Machine-learning and Mechanistic Modeling of Metastatic Breast Cancer After Neoadjuvant Treatment,” Plos Computational Biology 20, no. 5 (2024): e1012088.

[341] N. R. Thiruvengadam, P. Solaimani, M. Shrestha, S. Buller, R. Carson, and B. Reyes-Garcia, “The Efficacy of Real-time Computer-aided Detection of Colonic Neoplasia in Community Practice: A Pragmatic Randomized Controlled Trial,” Clinical Gastroenterology and Hepatology 22, no. 11 (2024): 2221-2230. e15.

[342] R. Djinbachian, M. Taghiakbari, A. Barkun, et al., “Optimized Computer-assisted Technique for Increasing Adenoma Detection During Colonoscopy: A Randomized Controlled Trial,” Surgical Endoscopy 39, no. 2 (2025): 1120-1127.

[343] T. K. Lui, C. P. Lam, E. W. To, et al., “Endocuff with or without Artificial Intelligence-Assisted Colonoscopy in Detection of Colorectal Adenoma: A Randomized Colonoscopy Trial,” American Journal of Gastroenterology 119, no. 7 (2024): 1318-1325.

[344] M. Desai, K. Ausk, D. Brannan, R. Chhabra, W. Chan, and M. Chiorean, “Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas during Screening and Surveillance Colonoscopy: Results from a Large, Prospective, US Multicenter, Randomized Clinical Trial,” American Journal of Gastroenterology 119, no. 7 (2024): 1383-1391.

[345] L. Yao, X. Li, Z. Wu, et al., “Effect of Artificial Intelligence on Novice-performed Colonoscopy: A Multicenter Randomized Controlled Tandem Study,” Gastrointestinal Endoscopy 99, no. 1 (2024): 91-99. e9.

[346] K. Miyaguchi, Y. Tsuzuki, N. Hirooka, et al., “Linked-color Imaging With or Without Artificial Intelligence for Adenoma Detection: A Randomized Trial,” Endoscopy 56, no. 5 (2024): 376-383.

[347] X. L. Yuan, W. Liu, Y. X. Lin, et al., “Effect of an Artificial Intelligence-assisted System on Endoscopic Diagnosis of Superficial Oesophageal Squamous Cell Carcinoma and Precancerous Lesions: A Multicentre, Tandem, Double-blind, Randomised Controlled Trial,” Lancet Gastroenterology and Hepatology 9, no. 1 (2024): 34-44.

[348] S. W. Li, L. H. Zhang, Y. Cai, et al., “Deep Learning Assists Detection of Esophageal Cancer and Precursor Lesions in a Prospective, Randomized Controlled Study,” Science Translational Medicine 16, no. 743 (2024): eadk5395.

[349] W. T. Tang, C. Q. Su, J. Lin, Z. W. Xia, S. S. Lu, and X. N. Hong, “T2-FLAIR Mismatch Sign and Machine Learning-based Multiparametric MRI Radiomics in Predicting IDH Mutant 1p/19q Non-co-deleted Diffuse Lower-grade Gliomas,” Clinical Radiology 79, no. 5 (2024): e750-e758.

[350] M. Salim, Y. Liu, M. Sorkhei, et al., “AI-based Selection of Individuals for Supplemental MRI in Population-based Breast Cancer Screening: The Randomized ScreenTrustMRI Trial,” Nature Medicine 30, no. 9 (2024): 2623-2630.

[351] A. Saha, J. S. Bosma, J. J. Twilt, et al., “Artificial Intelligence and Radiologists in Prostate Cancer Detection on MRI (PI-CAI): An International, Paired, Non-inferiority, Confirmatory Study,” The Lancet Oncology 25, no. 7 (2024): 879-887.

[352] R. Deng, Y. Liu, K. Wang, et al., “Comparison of MRI Artificial Intelligence-guided Cognitive Fusion-targeted Biopsy versus Routine Cognitive Fusion-targeted Prostate Biopsy in Prostate Cancer Diagnosis: A Randomized Controlled Trial,” BMC Medicine [Electronic Resource] 22, no. 1 (2024): 530.

[353] P. Papachristou, M. Soderholm, J. Pallon, et al., “Evaluation of an Artificial Intelligence-based Decision Support for the Detection of Cutaneous Melanoma in Primary Care: A Prospective Real-life Clinical Trial,” British Journal of Dermatology 191, no. 1 (2024): 125-133.

[354] O. Ortiz, M. Daca-Alvarez, L. Rivero-Sanchez, A. Z. Gimeno-Garcia, M. Carrillo-Palau, and V. Alvarez, “An Artificial Intelligence-assisted System versus White Light Endoscopy Alone for Adenoma Detection in Individuals With Lynch Syndrome (TIMELY): An International, Multicentre, Randomised Controlled Trial,” Lancet Gastroenterology and Hepatology 9, no. 9 (2024): 802-810.

[355] E. Nakao, T. Yoshio, Y. Kato, et al., “Randomized Controlled Trial of an Artificial Intelligence Diagnostic System for the Detection of Esophageal Squamous Cell Carcinoma in Clinical Practice,” Endoscopy 57, no. 3 (2025): 210-217.

[356] J. Scholer, M. Alavanja, T. de Lange, S. Yamamoto, P. Hedenstrom, and J. Varkey, “Impact of AI-aided Colonoscopy in Clinical Practice: A Prospective Randomised Controlled Trial,” BMJ Open Gastroenterology 11, no. 1 (2024): e001247.

[357] H. Zheng, L. Jian, L. Li, W. Liu, and W. Chen, “Prior Clinico-Radiological Features Informed Multi-Modal MR Images Convolution Neural Network: A Novel Deep Learning Framework for Prediction of Lymphovascular Invasion in Breast Cancer,” Cancer Medicine 13, no. 3 (2024): e6932.

[358] C. van Dooijeweert, R. N. Flach, N. D. Ter Hoeve, C. P. H. Vreuls, R. Goldschmeding, and J. E. Freund, “Clinical Implementation of Artificial-intelligence-assisted Detection of Breast Cancer Metastases in Sentinel Lymph Nodes: The CONFIDENT-B Single-center, Non-randomized Clinical Trial,” Nature Cancer 5, no. 8 (2024): 1195-1205.

[359] X. Luo, Y. Yang, S. Yin, et al., “Automated Segmentation of Brain Metastases With Deep Learning: A Multi-center, Randomized Crossover, Multi-reader Evaluation Study,” Neuro-Oncology 26, no. 11 (2024): 2140-2151.

[360] H. Wang, Y. Chen, J. Qiu, et al., “Machine Learning Based on SPECT/CT to Differentiate Bone Metastasis and Benign Bone Lesions in Lung Malignancy Patients,” Medical Physics 51, no. 4 (2024): 2578-2588.

[361] Y. F. Zhang, C. Zhou, S. Guo, et al., “Deep Learning Algorithm-based Multimodal MRI Radiomics and Pathomics Data Improve Prediction of Bone Metastases in Primary Prostate Cancer,” Journal of Cancer Research and Clinical Oncology 150, no. 2 (2024): 78.

[362] M. B. Zhang, Z. L. Meng, Y. Mao, et al., “Cervical Lymph Node Metastasis Prediction From Papillary Thyroid Carcinoma US Videos: A Prospective Multicenter Study,” BMC Medicine [Electronic Resource] 22, no. 1 (2024): 153.

[363] Y. Du, Y. Xiao, W. Guo, et al., “Development and Validation of an Ultrasound-based Deep Learning Radiomics Nomogram for Predicting the Malignant Risk of Ovarian Tumours,” Biomedical Engineering Online [Electronic Resource] 23, no. 1 (2024): 41.

[364] K. R. Quan, W. R. Lin, J. B. Hong, et al., “A Machine Learning Approach for Predicting Radiation-induced Hypothyroidism in Patients With Nasopharyngeal Carcinoma Undergoing Tomotherapy,” Scientific Reports 14, no. 1 (2024): 8436.

[365] L. Xu, H. Si, F. Zhuang, et al., “Predicting Therapeutic Response to Neoadjuvant Immunotherapy Based on an Integration Model in Resectable Stage IIIA (N2) Non-small Cell Lung Cancer,” Journal of Thoracic and Cardiovascular Surgery 169, no. 1 (2025): 242-253. e4.

[366] F. Schon, A. Kieslich, H. Nebelung, et al., “Comparative Analysis of Radiomics and Deep-learning Algorithms for Survival Prediction in Hepatocellular Carcinoma,” Scientific Reports 14, no. 1 (2024): 590.

[367] K. Atsou, A. Auperin, J. Guigay, S. Salas, and S. Benzekry, “Mechanistic Learning for Predicting Survival Outcomes in Head and Neck Squamous Cell Carcinoma,” CPT Pharmacometrics and System Pharmacology 14, no. 3 (2025): 540-550.

[368] C. M. Benedum, A. Sondhi, E. Fidyk, et al., “Replication of Real-World Evidence in Oncology Using Electronic Health Record Data Extracted by Machine Learning,” Cancers (Basel) 15, no. 6 (2023): 1853.

[369] P. Abrisqueta-Costa, J. A. Garcia-Marco, A. Gutierrez, et al., “Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients With Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study,” Cancers (Basel) 16, no. 23 (2024): 4004.

[370] J. Loscertales, P. Abrisqueta-Costa, A. Gutierrez, et al., “Real-World Evidence on the Clinical Characteristics and Management of Patients With Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study,” Cancers (Basel) 15, no. 16 (2023): 4047.

[371] D. S. Bitterman, E. Goldner, S. Finan, et al., “An End-to-End Natural Language Processing System for Automatically Extracting Radiation Therapy Events from Clinical Texts,” International Journal of Radiation and Oncology in Biology and Physics 117, no. 1 (2023): 262-273.

[372] G. Varma, R. K. Yenukoti, M. P. Kumar, et al., “A Deep Learning-Enabled Workflow to Estimate Real-World Progression-Free Survival in Patients with Metastatic Breast Cancer: Study Using Deidentified Electronic Health Records,” JMIR Cancer 11 (2025): e64697.

[373] R. Moulson, J. Law, A. Sacher, et al., “Real-World Outcomes of Patients With Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence,” Current Oncology 31, no. 4 (2024): 1947-1960.

[374] S. A. van Laar, K. B. Gombert-Handoko, H. J. Guchelaar, and J. Zwaveling, “An Electronic Health Record Text Mining Tool to Collect Real-World Drug Treatment Outcomes: A Validation Study in Patients with Metastatic Renal Cell Carcinoma,” Clinical Pharmacology & Therapeutics 108, no. 3 (2020): 644-652.

[375] Y. H. Karimi, D. W. Blayney, A. W. Kurian, et al., “Development and Use of Natural Language Processing for Identification of Distant Cancer Recurrence and Sites of Distant Recurrence Using Unstructured Electronic Health Record Data,” JCO Clinical Cancer Informatics 5 (2021): 469-478.

[376] X. Wang, H. Lee, B. Haaland, et al., “A Matching-based Machine Learning Approach to Estimating Optimal Dynamic Treatment Regimes With Time-to-event Outcomes,” Statistical Methods in Medical Research 33, no. 5 (2024): 794-806.

[377] T. Yamashita, Y. Wakata, H. Nakaguma, et al., “Machine Learning for Classification of Postoperative Patient Status Using Standardized Medical Data,” Computer Methods and Programs in Biomedicine 214 (2022): 106583.

[378] L. Hu, J. Ji, H. Liu, and R. Ennis, “A Flexible Approach for Assessing Heterogeneity of Causal Treatment Effects on Patient Survival Using Large Datasets With Clustered Observations,” International Journal of Environmental Research and Public Health 19, no. 22 (2022): 14903.

[379] O. Tredan, M. Laurent, M. Gilberg, et al., “Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated with Trastuzumab in the French National Hospital Database,” Cancer Informatics 21 (2022): 11769351221135134.

[380] Y. P. V. Mbous, Z. A. Siddiqui, M. Bharmal, et al., “Type of Pre-existing Chronic Conditions and Their Associations With Merkel Cell Carcinoma (MCC) Treatment: Prediction and Interpretation Using Machine Learning Methods,” PLoS ONE 20, no. 7 (2025): e0327964.

[381] R. Knevel and K. P. Liao, “From Real-world Electronic Health Record Data to Real-world Results Using Artificial Intelligence,” Annals of the Rheumatic Diseases 82, no. 3 (2023): 306-311.

[382] M. M. Voets, J. Veltman, C. H. Slump, S. Siesling, and H. Koffijberg, “Systematic Review of Health Economic Evaluations Focused on Artificial Intelligence in Healthcare: The Tortoise and the Cheetah,” Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research 25, no. 3 (2022): 340-349.

[383] P. S. Aravazhi, P. Gunasekaran, N. Z. Y. Benjamin, et al., “The Integration of Artificial Intelligence Into Clinical Medicine: Trends, Challenges, and Future Directions,” Disease-A-Month 71, no. 6 (2025): 101882.

[384] A. Aggarwal, S. Bharadwaj, G. Corredor, T. Pathak, S. Badve, and A. Madabhushi, “Artificial Intelligence in Digital Pathology—time for a Reality Check,” Nature Reviews Clinical Oncology 22, no. 4 (2025): 283-291.

[385] G. Duwe, D. Mercier, C. Wiesmann, et al., “Challenges and Perspectives in Use of Artificial Intelligence to Support Treatment Recommendations in Clinical Oncology,” Cancer Medicine 13, no. 12 (2024): e7398.

[386] K. Akimoto, K. Taparra, T. Brown, and M. I. Patel, “Diversity in Cancer Care: Current Challenges and Potential Solutions to Achieving Equity in Clinical Trial Participation,” Cancer Journal (Sudbury, Massachusetts) 29, no. 6 (2023): 310-315.

[387] M. G. Hanna, L. Pantanowitz, B. Jackson, et al., “Ethical and Bias Considerations in Artificial Intelligence/Machine Learning,” Modern Pathology 38, no. 3 (2025): 100686.

[388] L. H. Nazer, R. Zatarah, S. Waldrip, et al., “Bias in Artificial Intelligence Algorithms and Recommendations for Mitigation,” PLOS Digital Health 2, no. 6 (2023): e0000278.

[389] C. Elendu, D. C. Amaechi, T. C. Elendu, et al., “Ethical Implications of AI and Robotics in Healthcare: A Review,” Medicine 102, no. 50 (2023): e36671.

[390] W. Lotter, M. J. Hassett, N. Schultz, K. L. Kehl, E. M. Van Allen, and E. Cerami, “Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions,” Cancer Discovery 14, no. 5 (2024): 711-726.

[391] S. I. Lambert, M. Madi, S. Sopka, et al., “An Integrative Review on the Acceptance of Artificial Intelligence Among Healthcare Professionals in Hospitals,” NPJ Digital Medicine 6, no. 1 (2023): 111.

[392] A. Kiseleva, D. Kotzinos, and P. De Hert, “Transparency of AI in Healthcare as a Multilayered System of Accountabilities: Between Legal Requirements and Technical Limitations,” Frontiers in Artificial Intelligence 5 (2022): 879603.

[393] E. Marcus and J. Teuwen, “Artificial Intelligence and Explanation: How, Why, and When to Explain Black Boxes,” European Journal of Radiology 173 (2024): 111393.

[394] D. Muhammad and M. Bendechache, “Unveiling the Black Box: A Systematic Review of Explainable Artificial Intelligence in Medical Image Analysis,” Computational and Structural Biotechnology Journal 24 (2024): 542-560.

[395] R. Lavelle-Hill, G. Smith, H. Deininger, and K. Murayama, “An Explainable Artificial Intelligence Handbook for Psychologists: Methods, Opportunities, and Challenges,” Psychological Methods (2025).

[396] V. Hassija, V. Chamola, A. Mahapatra, et al., “Interpreting Black-Box Models: A Review on Explainable Artificial Intelligence,” Cognitive Computation 16, no. 1 (2024): 45-74.

[397] M. Harishbhai Tilala, P. Kumar Chenchala, A. Choppadandi, et al., “Ethical Considerations in the Use of Artificial Intelligence and Machine Learning in Health Care: A Comprehensive Review,” Cureus 16, no. 6 (2024): e62443.

[398] A. Arora, J. E. Alderman, J. Palmer, et al., “The Value of Standards for Health Datasets in Artificial Intelligence-based Applications,” Nature Medicine 29, no. 11 (2023): 2929-2938.

[399] N. Norori, Q. Hu, F. M. Aellen, F. D. Faraci, and A. Tzovara, “Addressing Bias in Big Data and AI for Health Care: A Call for Open Science,” Patterns (N Y) 2, no. 10 (2021): 100347.

[400] I. W. Price, S. Gerke, and I. G. Cohen. Liability for Use of Artificial Intelligence in medicine. In: B. Solaiman, and I. G. Cohen, editors. Research Handbook on Health, AI and the Law″ (Cheltenham, UK2024): 150-166.

[401] C. Cestonaro, A. Delicati, B. Marcante, L. Caenazzo, and P. Tozzo, “Defining Medical Liability When Artificial Intelligence Is Applied on Diagnostic Algorithms: A Systematic Review,” Frontiers in Medicine (Lausanne) 10 (2023): 1305756.

[402] F. Boge and A. Mosig, “Causality and Scientific Explanation of Artificial Intelligence Systems in Biomedicine,” Pflugers Archiv: European Journal of Physiology 477, no. 4 (2025): 543-554.

[403] Y. Abas Mohamed, B. Ee Khoo, M. Shahrimie Mohd Asaari, M. Ezane Aziz, and F. Rahiman Ghazali, “Decoding the Black Box: Explainable AI (XAI) for Cancer Diagnosis, Prognosis, and Treatment Planning-A state-of-the Art Systematic Review,” International Journal of Medical Informatics 193 (2025): 105689.

[404] B. Mueller, T. Kinoshita, A. Peebles, M. A. Graber, and S. Lee, “Artificial Intelligence and Machine Learning in Emergency Medicine: A Narrative Review,” Acute Medicine & Surgery 9, no. 1 (2022): e740.

[405] H. Patel, A. Chopra, and D. S. Rajput, “Myint Aung D. Interactive XAI for Personalized and Trusted Healthcare: Need of the Hour,” International Journal of Surgery 110, no. 9 (2024): 5869-5870.

[406] B. A. van Dort, J. Lopez Canizares, R. Marcilly, L. Peute, and D. Sent, “Enhancing Clinical Decision Support: A Heuristic Evaluation of Explainable AI in Healthcare Dashboards,” Studies in Health Technology and Informatics 327 (2025): 343-347.

[407] N. Mitra, J. Roy, and D. Small, “The Future of Causal Inference,” American Journal of Epidemiology 191, no. 10 (2022): 1671-1676.

[408] P. Linardatos, V. Papastefanopoulos, S. Kotsiantis, and A. I. Explainable, “A Review of Machine Learning Interpretability Methods,” Entropy (Basel) 23, no. 1 (2020): 18.

[409] X. Yang, J. Jia, X. Zhou, and S. Wang, “The Future of Artificial Intelligence: Time to Embrace More International Collaboration,” Innovation (Cambridge) 5, no. 6 (2024): 100703.

[410] Q. Liu, C. Huang, G. Zhan, Y. Guan, and S. Li, “The Need for Expansion of Global Collaborations on AI in Oncology,” Lancet 405, no. 10487 (2025): 1339.

[411] M. Tajabadi, L. Grabenhenrich, A. Ribeiro, M. Leyer, and D. Heider, “Sharing Data with Shared Benefits: Artificial Intelligence Perspective,” Journal of Medical Internet Research [Electronic Resource] 25 (2023): e47540.

[412] C. Mennella, U. Maniscalco, G. De Pietro, and M. Esposito, “Ethical and Regulatory Challenges of AI Technologies in Healthcare: A Narrative Review,” Heliyon 10, no. 4 (2024): e26297.

[413] N. Schwalbe and B. Wahl, “Artificial Intelligence and the Future of Global Health,” Lancet 395, no. 10236 (2020): 1579-1586.

[414] F. Olan, E. Ogiemwonyi Arakpogun, J. Suklan, F. Nakpodia, N. Damij, and U. Jayawickrama, “Artificial Intelligence and Knowledge Sharing: Contributing Factors to Organizational Performance,” Journal of Business Research 145 (2022): 605-615.

[415] V. S. Viswanathan, V. Parmar, and A. Madabhushi, “Towards Equitable AI in Oncology,” Nature Reviews Clinical Oncology 21, no. 8 (2024): 628-637.

[416] D. Ueda, T. Kakinuma, S. Fujita, et al., “Fairness of Artificial Intelligence in Healthcare: Review and Recommendations,” Japanese Journal of Radiology 42, no. 1 (2024): 3-15.

[417] A. Singhal, N. Neveditsin, H. Tanveer, and V. Mago, “Toward Fairness, Accountability, Transparency, and Ethics in AI for Social Media and Health Care: Scoping Review,” JMIR Medical Informatics Medical Informatics 12 (2024): e50048.

[418] M. M. Mir, G. M. Mir, N. T. Raina, et al., “Application of Artificial Intelligence in Medical Education: Current Scenario and Future Perspectives,” Journal of Advances in Medical Education & Professionalism 11, no. 3 (2023): 133-140.

[419] S. Garcia-Saiso, M. Marti, K. Pesce, et al., “Artificial Intelligence as a Potential Catalyst to a More Equitable Cancer Care,” JMIR Cancer 10 (2024): e57276.

[420] A. A. Funa and R. A. E. Gabay, “Policy Guidelines and Recommendations on AI Use in Teaching and Learning: A Meta-synthesis Study,” Social Sciences & Humanities Open 11 (2025): 101221.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.